株探米国株
英語
エドガーで原本を確認する
0000064463 false 0000064463 2022-01-21 2022-01-21 0000064463 SNLH:CommonStockParValueMember 2022-01-21 2022-01-21 0000064463 SNLH:Sec9.0SeriesCumulativePerpetualMember 2022-01-21 2022-01-21 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

UNITED STATES 

SECURITIES AND EXCHANGE COMMISSION 

WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT 

PURSUANT TO SECTION 13 OR 15(d) 

OF THE SECURITIES EXCHANGE ACT OF 1934

 

Date of Report (Date of earliest event reported) January 21, 2022 (January 14, 2022)

 

SOLUNA HOLDINGS, INC. 

(Exact name of registrant as specified in its charter)

 

Nevada   000-06890   14-1462255
(State or other jurisdiction
of Incorporation)
  (Commission
File Number)
  (IRS Employer
Identification Number)

 

 

325 Washington Avenue Extension

Albany, New York

  12205
(Address of registrant's principal executive office)   (Zip code)

 

(518) 218-2550

(Registrant's telephone number, including area code)

 

N/A

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading symbol(s)   Name of each exchange on which
registered

Common Stock, par value 

$0.001 per share

  SNLH   The Nasdaq Stock Market LLC
9.0% Series A Cumulative Perpetual
Preferred Stock, par value $0.001 per share
  SLNHP   The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934.

  

Emerging growth company ☐    

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 


 

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

 

In connection with the continued employment of each of Michael Toporek as Chief Executive Officer of Soluna Holdings, Inc. (the “Company” or “our”), and Moshe Binyamin as President of MTI Instruments, Inc. (“MTI”), our wholly owned subsidiary, effective as of January 14, 2022, the Company entered into an employment agreement with Michael Toporek, our current Chief Executive Officer (the “Toporek Employment Agreement”), and, effective January 20, 2022, the Company entered into an employment agreement with Moshe Binyamin, current President of MTI (the “Binyamin Employment Agreement”). The Toporek Employment Agreement and the Binyamin Employment Agreement were each approved by the compensation committee (the “Compensation Committee”) of the board of directors (the “Board”) of the Company.

 

In connection with the Binyamin Employment Agreement also effective as of January 20, 2022, the Board elected Mr. Binyamin, MTI’s then current President, to the offices of President and Chief Executive Officer of MTI. Mr. Binyamin does not have any family relationships with any of the Company’s Directors or executive officers, is not a party to any transactions of the type listed in Item 404(a) of Regulation S-K, and was not appointed pursuant to any arrangement or understanding with any other person. Mr. Binyamin’s biography is contained in the Company’s proxy statement for the Company’s annual meeting of stockholders held on June 9, 2021, which was filed with the Securities and Exchange Commission on May 18, 2021, and is incorporated herein by reference.

 

Pursuant to the Toporek Employment Agreement, Mr. Toporek agreed to continue to serve as our Chief Executive Officer for an initial term of three years, to be extended automatically for successive one-year periods, in consideration for an annual cash salary of $300,000, which will be subject to annual review by the Board or its Compensation Committee and may be increased from time to time by the Board or the Compensation Committee (“Toporek Base Salary”). The Toporek Employment Agreement provides for (i) annual performance bonuses based on attainment of one or more individual or business performance goals proposed by Mr. Toporek and approved by the Compensation Committee in its sole discretion (the “Annual Performance Bonus” and such target Annual Performance Bonus for a given calendar year, the “Target Performance Bonus”); (ii) a one-time option previously granted by the Compensation Committee on May 13, 2021, to purchase 500,000 shares (the “Shares”) of the Company’s common stock, par value $0.001 per share (“Common Stock”) at a per -share exercise price equal to $6.84 per share, subject to vesting over a three-year period after the grant date and all of the other terms and conditions of the Company’s 2021 Stock Incentive Plan and an individual award agreement entered into between the Company and Mr. Toporek(the “LTI Award”); (iii) future outperformance awards upon attainment of each Market Capitalization Growth Target (as defined in the Toporek Employment Agreement) which will be fully vested upon grant and delivered subject to certain conditions as set forth in the Toporek Employment Agreement (the “Outperformance Awards”); and (iv) eligibility for employee benefit plans in effect until Mr. Toporek’s employment with the Company is terminated.

 

Pursuant to the Toporek Employment Agreement, if Mr. Toporek is terminated for any reason other than termination without cause or resignation for good reason, he is entitled to receive (i) a lump sum payment in the amount equal to the sum of Mr. Toporek’s earned but unpaid Toporek Base Salary through the date of termination, (ii) his earned but unpaid Annual Performance Bonus for the calendar year preceding the date of termination, (iii) his accrued but unused vacation days as of the date of termination, (iii) reimbursement for any unreimbursed business expenses incurred through the date of termination, and (iv) any other benefits or rights Mr. Toporek will have accrued or earned through his date of termination under the terms of any employee benefit plan. Additionally, if Mr. Toporek is terminated without cause or he resigns for good reason, subject to satisfaction of certain release conditions, he will also be entitled to coverage under any health insurance plan covering Mr. Toporek for 12 months after the termination of his employment, one year of his then-current Toporek Base Salary and the Target Performance Bonus for the calendar year containing the date of termination, both paid in a single lump sum in cash on the first regular Company payroll date next following the 60th calendar day following the date of termination.

 

Pursuant the Binyamin Employment Agreement, Mr. Binyamin agreed to serve as President and Chief Executive Officer of MTI for an initial term of 24 calendar months, to be extended automatically for successive 12-month periods, in consideration for an annual cash salary of $180,350, which will be subject to annual review by the Board or its Compensation Committee and may be increased from time to time at the Board or the Compensation Committee’s sole discretion (“Binyamin Base Salary”). The Binyamin Employment Agreement provides for: performance bonuses as determined by the Compensation Committee (each a “Binyamin Performance Bonus”); a cash incentive payment in the event of a Change in Control (as defined in the Binyamin Employment Agreement) occurring while Mr. Binyamin is in active employment or within three months following its termination by death, disability, without cause or his resignation for good reason, based on the consideration received by MTI following a Change in Control; and employee benefits in accordance with our policies, and remain in effect until Mr. Binyamin’s employment with MTI is terminated.

 

 


  

Pursuant to the Binyamin Employment Agreement, if Mr. Binyamin is terminated for any reason other than termination without cause or resignation for good reason, he is entitled to receive (i) a lump sum payment in an amount equal to the sum of Mr. Binyamin’s earned but unpaid Binyamin Base Salary through the date of termination, (ii) his earned but unpaid Annual Performance Bonus for the calendar year preceding the date of termination, (iii) his accrued but unused vacation days as of the date of termination, (iii) reimbursement for any approved and unreimbursed business expenses incurred through the date of termination, and (iv) any other benefits or rights Mr. Binyamin will have accrued or earned through his date of termination under the terms of any employee benefit plan (collectively, the “Binyamin Accrued Benefits”). Additionally, if Mr. Binyamin is terminated without cause or if he resigns for good reason, subject to satisfaction of certain release conditions, he will also be entitled to coverage under any health insurance plan covering Mr. Binyamin, for 12 months after the termination of his employment, 12 months of his then-current Binyamin Base Salary payable in 12 equal monthly installments, and any Performance Bonus earned but unpaid for the most recently completed bonus year preceding the date of termination, paid in a single lump sum in cash on the first regular Company payroll date next following the 60th calendar day following the date of termination.

 

The foregoing description of the Toporek Employment Agreement and the Binyamin Employment Agreement does not purport to be complete and is qualified in its entirety by reference to the full text of the Toporek Employment Agreement and the Binyamin Employment Agreement, copies of which are filed as Exhibits 10.1 and 10.2 hereto and incorporated herein by reference.

 

 

Item 9.01.   Financial Statements and Exhibits

 

(d) Exhibits

 

Exhibit No. Description

 

10.1+ Employment Agreement, by and between Soluna Holdings, Inc. and Michael Toporek, dated as of January 14, 2022
10.2+ Employment Agreement, by and between MTI Instruments, Inc. and Moshe Binyamin, dated as of January 20, 2022

 

 + Represents management contract or compensation plan or arrangement.

 

 


  

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.  

 

Date: January 21, 2022 SOLUNA HOLDINGS, INC.  
       
  By:   /s/ Jessica L. Thomas  
   

Name: Jessica L. Thomas  

Title: Chief Financial Officer  

 

 

 

 

 

 

 


 

EX-10.1 2 g082575_ex10-1.htm EXHIBIT 10.1

 

Exhibit 10.1

 

SOLUNA HOLDINGS, INC.
EMPLOYMENT AGREEMENT

 

Soluna Holdings, Inc., a Nevada corporation (the “Company”) and Michael Toporek (the “Executive”) (the Company and the Executive each a “Party” and, collectively, the “Parties”) enter into this EMPLOYMENT AGREEMENT (this “Agreement”) dated as of January 14, 2022 (the “Effective Date”).

 

W I T N E S S E T H

 

WHEREAS, the Executive is employed by the Company as its Chief Executive Officer;

 

WHEREAS, the Company and the Executive have agreed that the Executive will make a full-time commitment to his role as the Company’s Chief Executive Officer, with the goal of growing the Company’s cryptocurrency and Instruments businesses and market capitalization, which will require the Executive to scale back the Executive’s responsibilities and positions with Brookstone Partners and other third parties;

 

WHEREAS, as an incentive for the Executive’s commitment, the Board of Directors of the Company (the “Board”) desires to offer the Executive the compensation, benefits, and other rights and entitlements set forth in this Agreement, subject to the Executive complying with the Executive’s obligations under this Agreement; and

 

WHEREAS, the Company desires to continue employing the Executive, and the Executive desires to continue to be employed by the Company, in each case, on the terms and conditions set forth herein.

 

NOW, THEREFORE, in consideration of the foregoing, of the mutual promises contained herein, and of other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties hereto hereby agree as follows:

 

1.               POSITION AND DUTIES.

 

(a)              During the “Employment Term” (as defined below), the Executive will serve as the Chief Executive Officer of the Company. In this capacity, the Executive will have the duties, authorities and responsibilities commensurate with the duties, authorities and responsibilities of persons in similar capacities in similarly sized companies, and such other duties, authorities and responsibilities not inconsistent with the Executive’s position as may be assigned to the Executive by the Board from time to time. The Executive will report directly to the Board.

 

(b)              The Executive’s principal place of employment with the Company will be in New York City, New York, provided that the Executive understands and agrees that the Executive may be required to travel from time to time for business purposes.

 

1 


(c)               During the Employment Term, the Executive will faithfully serve the Company and devote all of the Executive’s business time, energy, business judgment, knowledge and skill, and the Executive’s best efforts, to the performance of the Executive’s duties with the Company, provided that the foregoing will not prevent the Executive from (i) serving on the boards of directors of non-profit organizations, (ii) participating in charitable, civic, educational, professional, community or industry affairs, and (iii) managing the Executive’s passive personal investments, so long as such activities do not, individually or in the aggregate, interfere or conflict with the Executive’s duties, obligations and restrictions hereunder or create a potential business or fiduciary conflict. The Parties further agree and acknowledge that, without limiting the foregoing, the Executive will be permitted to provide the “Other Services” described in Section 6(d)(iii) hereof, subject to the terms and conditions of such Section.

 

2.                EMPLOYMENT TERM. The Executive’s employment under this Agreement will commence on the Effective Date and will continue for an initial term of three (3) years (the “Initial Term”). Effective upon the expiration of the Initial Term and of each “Additional Term” (as defined below), the term of this Agreement will be automatically extended for successive one (1)-year periods (each, an “Additional Term”), provided, however, that either Party may elect not to extend this Agreement by giving written notice to the other Party at least one hundred twenty (120) calendar days prior to the expiration of the Initial Term or any Additional Term, as applicable. Notwithstanding the foregoing, the Executive’s employment hereunder may be earlier terminated in accordance with Section 4 hereof. The effective date of any termination of the Executive’s employment hereunder is hereinafter referred to as the “Termination Date”, and the period of time between the Effective Date and the Termination Date is hereinafter referred to as the “Employment Term”. Effective upon any Termination Date, this Agreement will automatically terminate and will be of no further force or effect, except as otherwise provided in Section 14(a) hereof, and the Executive shall immediately resign, in writing, from all positions then held by the Executive with the Company and its affiliates unless otherwise agreed to by the Company and the Executive.

 

3.                COMPENSATION AND BENEFITS.

 

(a)              BASE SALARY. During the Employment Term, the Company will pay to the Executive a base salary at an annualized rate of three hundred thousand dollars ($300,000), payable in accordance with the regular payroll practices of the Company, but not less frequently than monthly. The Executive’s Base Salary will be subject to annual review by the Board or its Compensation Committee (the “Committee”), and may be increased, but not decreased, from time to time by the Board or the Committee (typically, during the first calendar quarter of a calendar year, effective retroactively as of the beginning of such year). The base salary, as determined herein and adjusted from time to time, will constitute “Base Salary” for purposes of this Agreement.

 

2 


(b)              ANNUAL PERFORMANCE BONUS. For each calendar year ending during the Employment Term (prorated for any partial year, other than the year containing the Effective Date), the Executive will be eligible to earn an annual cash performance bonus based on attainment of one or more individual or business performance goals proposed by the Executive and approved by the Committee in its sole discretion (the “Annual Performance Bonus”). The target Annual Performance Bonus opportunity for a given calendar year, which will be achieved upon attainment of 100% of the applicable performance goals, will be equal to 33.33% of the Executive’s Base Salary in effect as of January 1 of such calendar year (such Base Salary to be determined by the Board or the Committee during the first calendar quarter of such year) (the “Target Performance Bonus”). If actual performance for a given calendar year is greater or lower than 100% of the applicable performance goals, the Annual Performance Bonus amount for such year will be increased above, or reduced below, the Target Performance Bonus, respectively, as determined by the Committee or the Board using straight line interpolation, subject to a maximum Annual Performance Bonus amount equal to 83.33% of the Executive’s Base Salary in effect as of January 1 of such calendar year (such Base Salary to be determined by the Board or the Committee during the first calendar quarter of such year), with no minimum Annual Performance Bonus amount. The Annual Performance Bonus achieved for a calendar year will be paid on or before March 15 of the immediately following calendar year, contingent on the Executive’s continued employment with the Company through the last day of the calendar year to which the Annual Performance Bonus relates.

 

(c)               LONG-TERM INCENTIVE AWARD. In consideration of the Executive’s services to be performed under this Agreement, on May 13, 2021 the Company granted to the Executive a one-time option (the “LTI Award”) to purchase five hundred thousand (500,000) shares of the Company’s common stock (the “Shares”) at a per-Share exercise price equal to $6.84 per Share, subject to vesting over a three (3) year period after the grant date and all of the other terms and conditions of the Company’s 2021 Stock Incentive Plan (together with any successor equity plan, the “Equity Plan”) and an individual award agreement (collectively, the “LTI Documents”). In the event of any conflict between any terms of this Agreement and any terms of the LTI Documents, the terms of the LTI Documents will prevail.

 

3 


(d)               FUTURE OUTPERFORMANCE AWARDS.

 

(i)                                                                  To further incentivize the Executive to achieve and exceed the Company’s business goals, within seven (7) calendar days after each achievement of a “Market Capitalization Growth Target” (as defined below) during the Employment Term and, provided the Executive’s employment and the Employment Term end other than in accordance with Section 4(c) or 4(f) below and the Executive has complied with the “Release Condition” (as defined below), if applicable, one hundred eighty (180) calendar days following the Termination Date (the date of each such achievement, a “Target Achievement Date”), the Company will grant to the Executive, subject to the Executive continuing to comply with all applicable provisions of this Agreement (including Section 6) and making or entering into arrangements satisfactory to the Company, prior to each applicable grant date, to comply with all applicable tax withholding obligations, an additional award in respect of the number of Shares that is equal to the result of dividing two million five hundred thousand dollars ($2,500,000) by the quotient of (x) Baseline Market Capitalization (as established immediately following the determination of the achievement of the Market Capitalization Growth Target) divided by (y) the Average Number Of Shares (as defined below) outstanding on the Applicable Exchange during the one hundred twenty (120) calendar days prior to the Target Achievement Date (as determined by the Company in its sole and absolute discretion and approved by the audit committee of the Board based on the Company’s most recent annual audited financial statements or reviewed quarterly financial statements, and any Share issuances subsequent to the reporting period covered by such statements) (the resulting number of Shares, the “Subject Shares”, and each such award, an “Outperformance Award”), with no limitation on the number of Outperformance Awards which may be earned. For purposes of clarity, and illustration, the Executive may earn more than one Outperformance Award as of any given date upon satisfaction of the criteria set forth herein. Each Outperformance Award will be fully- vested upon grant and delivered on the grant date by: (A) payment of a cash lump sum in an amount equal to the product of fifty percent (50%) (one hundred percent (100%) in the case of any Outperformance Award granted on or after the Termination Date) of the total number of Subject Shares (including any fractional shares) multiplied by the “Closing Share Price” (as defined below) as of the Target Achievement Date, and (B) in the case of any Outperformance Award granted before the Termination Date, delivery of Shares equal to the remaining fifty percent (50%) of the Subject Shares subject only to a six (6) month lockup restriction and all of the other terms and conditions of the Equity Plan and an individual award agreement to be provided by the Company to the Executive at the time of grant (collectively, the “Outperformance Award Documents”). Notwithstanding the foregoing, (a) in lieu of any fractional Share issuable pursuant to an Outperformance Award, the Company shall, on the grant date of such Outperformance Award, make a lump sum cash payment to Executive equal to the product of such fraction multiplied by the Closing Share Price as of the Target Achievement Date, and (b) if the Committee determines, in its sole and absolute discretion, that there are fewer authorized but unissued whole Shares available for issuance under the Equity Plan than the total number of whole Shares that are required to be issued pursuant to an Outperformance Award under this Section 3(d) (the number of whole Shares constituting such shortfall, the “Shortfall Shares”), then, in lieu of the Shortfall Shares, the Company will make a lump sum cash payment to Executive on the Outperformance Award grant date equal to the product of the Shortfall Shares multiplied by the Closing Share Price on the grant date. In the event of any conflict between any terms of this Agreement and any terms of the Outperformance Award Documents, the terms of the Outperformance Award Documents will prevail, except to the extent otherwise expressly provided in the Outperformance Award Documents. For purposes of this Agreement, “Average Number Of Shares” shall mean the sum of Company Shares on each of the trading days within the 120 calendar period divided by the number of trading days in the 120 day calendar period.

 

(ii)              For each calendar year during the Employment Term, the Company shall make commercially reasonable efforts to earmark the minimum number of authorized but unissued Shares under the Equity Plan that it determines, in its sole and absolute discretion (using the Closing Share Price as of January 1 of such year), would be sufficient to satisfy its obligations to issue Shares pursuant to two (2) Outperformance Awards; provided that, for purposes of such earmarking, first priority shall be given to (a) annual equity awards required to be granted under the Equity Plan to each of the President and Chief Executive Officer, Chief Technology Officer and Vice President Corporate Development of Soluna Computing, Inc. (f/k/a EcoChain, Inc.), pursuant to their respective employment agreements with Soluna Computing, Inc., (b) annual equity awards required to be granted under the Equity Plan to ML&K Contractor pursuant to the consulting agreement by and between Soluna Computing, Inc. and ML&K Contractor, and (c) any equity awards that the Company desires to grant under the Equity Plan to existing employees or other individual service providers (including directors) and to other individuals as inducement to commence or maintain their employment or other engagement (including service as a director) with the Company. Notwithstanding anything in this Agreement to the contrary, the Company makes no guarantee that sufficient Shares will be available for grants pursuant to any Outperformance Award.

 

4 


(iii)            The Committee shall make all determinations and calculations under and with respect to this Section 3(d) (including, without limitation, as to the date of achievement of each Market Capitalization Growth Target) in its sole and absolute discretion, and the Committee’s determinations and calculations will be final and binding on both Parties.

 

(iv)            For purposes of this Section 3(d), the following terms shall have the following meanings:

 

“Applicable Exchange” means the principal securities exchange or trading market where the Shares are listed or traded.

 

“Average Market Capitalization Growth Amount” means, as of any date of determination, the amount equal to (a) the sum of the Market Capitalization Growth Amounts as of each trading day during the one hundred twenty (120) consecutive calendar day period ending on such date divided by (b) the number of trading days on the Applicable Exchange during such period.

  

“Baseline Market Capitalization” means, as of any date of determination, the sum of:

 

A. $86,850,000 (representing the estimated market capitalization of the Company as of May 13, 2021), plus

 

B. for each Market Capitalization Growth Target achieved, one hundred million dollars ($100,000,000), plus

 

C. the aggregate amount of cash proceeds received by the Company pursuant to each issuance of Shares, including in settlement of any stock options or similar equity awards (other than “Soluna Share Issuances” as defined below) and any other capital event directly impacting the Market Capitalization (as determined by the Board in its sole and absolute discretion), on or after May 13, 2021, plus

 

D. the aggregate of all Soluna Share Issuance Amounts associated with each Soluna Share Issuance that has occurred as of the date of determination, plus

 

5 


E. The aggregate dollar value of any Shares issued by the Company in connection with any event described in Rule 145(a)(2) or (3) promulgated under the Securities Act of 1933, as amended, subsequent to May 13, 2021.

 

“Closing Share Price” means, as of any date of determination, the closing price per Share on the Applicable Exchange as reported by Bloomberg, LP as of such date.

 

“Confirmation Period” means, as of any date of determination, a consecutive period of days ending on such date that includes twenty (20) trading days.

 

“Confirmation Period Market Capitalization Growth Amount” means, as of any date of determination, the amount equal to (a) the sum of the Market Capitalization Growth Amounts as of each trading day during the Confirmation Period ending on such date divided by (b) twenty (20).

 

“Market Capitalization” means, as of any date of determination, the product of the Closing Share Price as of such date and the number of Shares outstanding as of such date (as determined by the Company in its sole and absolute discretion and approved by the audit committee of the Board based on the Company’s most recent annual audited financial statements or reviewed quarterly financial statements, and any Share issuances subsequent to the reporting period covered by such statements).

 

“Market Capitalization Growth Amount” means, as of any date of determination, the amount equal to (a) Market Capitalization as of such date less (b) Baseline Market Capitalization as of such date.

 

“Market Capitalization Growth Target” means, with respect to each test on such date of determination, achievement of (a) an Average Market Capitalization Growth Amount as of such date of at least one hundred million dollars ($100,000,000) and (b) a Confirmation Period Market Capitalization Growth Amount with respect to each test on such date of at least eighty five million dollars ($85,000,000).

 

“Soluna Share Issuance” means each issuance of Shares pursuant to (a) the Termination Agreement, dated as of August 11, 2021, by and among the Company, EcoChain, Inc. and Harmattan Energy Ltd., formerly known as Soluna Technologies, Ltd., and (b) the Agreement and Plan of Merger, dated as of August 11, 2021, by and among the Company, SCI Merger Sub, Inc., and Soluna Computing, Inc.

 

“Soluna Share Issuance Amount” means, for each Soluna Share Issuance, the amount equal to (a) the number of Shares issued pursuant to such Soluna Share Issuance multiplied by (b) the Soluna Share Price.

 

“Soluna Share Price” means $7.43, as adjusted for any split or subdivision of Shares after May 13, 2021.

 

6 


    (iv)       The provisions of this Section 3(d) shall be interpreted and applied in a manner consistent with the examples set forth in Exhibit A hereto. However, Exhibit A is intended for illustrative purposes only and will not be binding on the Parties, and no representation or warranty is made with respect to any of the scenarios or amounts set forth therein.

 

(e)               EMPLOYEE BENEFIT PLANS. During the Employment Term, the Executive will be eligible to participate in any employee benefit plan maintained by the Company for the benefit of its employees generally, subject to all of the terms and conditions (including eligibility requirements) of such plan. Notwithstanding the foregoing, the Company may modify or terminate any employee benefit plan at any time, in its sole and absolute discretion.

 

(f)                VACATIONS. During the Employment Term, the Executive will be entitled to paid vacation in accordance with the Company’s vacation policy as in effect from time to time. Vacation may be taken at such times and intervals as the Executive determines, subject to the business needs of the Company.

 

(g)              BUSINESS EXPENSES. Upon presentation of reasonable substantiation and documentation as the Company may specify from time to time, the Executive will be reimbursed in accordance with the Company’s expense reimbursement policy for all reasonable out-of-pocket business expenses incurred and paid by the Executive during the Employment Term in connection with the performance of the Executive’s duties hereunder.

 

(h)              LEGAL FEES. Upon presentation of appropriate documentation, the Company will pay the Executive’s reasonable counsel fees incurred in connection with the negotiation and documentation of this Agreement, up to a maximum of twenty thousand dollars ($20,000), which will be paid within sixty (60) days following the Effective Date, provided that the Executive is still employed at the time of such payment.

 

4.                TERMINATION. The Executive’s employment and the Employment Term will terminate on the first of the following to occur:

 

(a)               DEATH. Automatically and immediately upon the date of death of the Executive.

 

(b)              TERMINATION DUE TO DISABILITY. Immediately upon written notice by the Company to the Executive of termination due to Disability. For purposes of this Agreement, “Disability” means the inability of the Executive to perform the Executive’s material duties hereunder due to a physical or mental injury, infirmity or incapacity for one hundred eighty (180) calendar days in any 365 calendar day period, as determined by the Board in its reasonable discretion. The Executive will cooperate in all respects with the Company if a question arises as to whether the Executive has become Disabled (including, without limitation, submitting to reasonable examinations by one or more medical doctors and other health care specialists selected by the Company and authorizing such medical doctors and other health care specialists to discuss the Executive’s condition with the Company).

 

7 


(c)            TERMINATION FOR CAUSE. Immediately upon written notice by the Company to the Executive of a termination for Cause. For purposes of this Agreement, “Cause” means any of the following:

 

(i)                The Executive’s theft, fraud (which, if arising out of third-party, non-Group Company, related proceedings involving the Executive, has or, in the good faith judgment of the Board, could reasonably be expected to have, a detrimental effect on a Group Company’s reputation or business), embezzlement, breach of fiduciary duty, or material falsification of any documents or records of the Company, its subsidiaries or other affiliates (each, a “Group Company”);

 

(ii)               The Executive’s dishonesty or willful misconduct which is reasonably related to a Group Company and has or, in the good faith judgment of the Board, could be expected to have, a material detrimental effect on a Group Company’s reputation or business;

 

(iii)              The Executive’s failure to abide by a Group Company’s code of conduct or other policies (including policies relating to confidentiality and reasonable workplace conduct) made available to the Executive which has or, in the good faith judgment of the Board, could be expected to have, a material detrimental effect on a Group Company’s reputation or business;

 

(iv)              The Executive’s unauthorized use, misappropriation, destruction or diversion of any corporate opportunity or any material tangible or intangible asset of a Group Company (including the Executive’s improper use or disclosure of a Group Company’s confidential or proprietary information);

 

(v)               any misconduct, gross negligence or malfeasance of the Executive which is reasonably related to a Group Company, or that has or, in the good faith judgment of the Board, could reasonably be expected to have, a material detrimental effect on a Group Company’s reputation or business;

 

(vi)              The Executive’s repeated willful failure to perform the Executive’s assigned duties after written notice from the Board of such failure;

 

(vii)             any material breach by the Executive of this Agreement; or

 

(viii)           The Executive’s conviction (including any plea of guilty or nolo contendere) of any felony or any other criminal act involving fraud, dishonesty or misappropriation or that materially and permanently impairs the Executive’s ability to perform his duties with a Group Company.

 

8 


Any determination of Cause will be made by a resolution approved by a majority of the members of the Board, provided that no such determination may be made until the Executive has been given written notice detailing the specific Cause event and a period of thirty (30) calendar days following receipt of such notice to cure such event (if susceptible to cure in the Board’s reasonable determination) to the satisfaction of the Board, or, if such event is not so cured, an opportunity on at least five (5) business days’ advance written notice to appear (with legal counsel) before the Board to discuss the specific circumstances alleged to constitute the Cause event. Notwithstanding anything to the contrary contained herein, the Executive’s right to cure and appear before the Board with legal counsel as set forth in the preceding sentence will not apply if there are habitual or repeated breaches by the Executive.

 

(d)              TERMINATION WITHOUT CAUSE. Immediately upon written notice by the Company to the Executive of an involuntary termination without Cause (which, for the avoidance of doubt, will not include any termination described in Sections 4(a) or 4(b) above or non-extension by the Company described in Section 4(g) below), provided however, that thirty (30) calendar days written notice shall be provided if termination under this paragraph occurs between any Target Achievement Date and the grant date of the resulting Outperformance Award.

 

(e)              RESIGNATION FOR GOOD REASON. Upon written notice by the Executive to the Company of a termination for Good Reason (which, for the avoidance of doubt, will not include any non-extension by the Executive described in Section 4(g) below). For purposes of this Agreement, “Good Reason” means the occurrence of any of the following events, without the express written consent of the Executive, unless such events are fully corrected in all material respects by the Company within thirty (30) calendar days following written notification by the Executive to the Company of the occurrence of one of the reasons set forth below:

 

(i)                any diminution in the Executive’s Base Salary;

 

(ii)               material diminution in the Executive’s duties, authorities or responsibilities (other than temporarily while physically or mentally incapacitated or as required by applicable law);

 

(iii)              relocation of the Executive’s primary work location by more than thirty (30) miles from the principal location from which he works as of the Effective Date, which increases the Executive’s one-way commute; or

 

(iv)              Any other action or inaction of the Company that constitutes a material breach of the Agreement.

 

The Executive must provide the Company with a written notice detailing the specific circumstances alleged to constitute Good Reason within ninety (90) calendar days after the first occurrence of such circumstances, and actually terminate employment within thirty (30) calendar days following the expiration of the Company’s thirty (30)-day cure period described above. Otherwise, any claim of such circumstances as “Good Reason” will be deemed irrevocably waived by the Executive.

 

9 


(f)               RESIGNATION WITHOUT GOOD REASON. Upon not less than sixty (60) calendar days’ prior written notice by the Executive to the Company of the Executive’s voluntary termination of employment without Good Reason (which the Company may, in its sole discretion, make effective earlier than any notice date).

 

(g)              NON-EXTENSION OF AGREEMENT. Upon the expiration of the Employment Term due to a non-extension of the Agreement by the Company or the Executive pursuant to Section 2 hereof.

 

5.                CONSEQUENCES OF TERMINATION.

 

(a)              DEATH; TERMINATION DUE TO DISABILITY; TERMINATION FOR CAUSE; RESIGNATION WITHOUT GOOD REASON; NON-EXTENSION OF AGREEMENT. In the event that the Executive’s employment and the Employment Term end in accordance with Section 4(a), 4(b), 4(c), 4(f) or 4(g), the Executive (or the Executive’s estate, as applicable) will be entitled to the following (collectively, the “Accrued Benefits”), subject to Section 11 below:

 

   (i)                any previously earned but unpaid Base Salary through the Termination Date, paid within sixty (60) calendar days following the Termination Date, or on such earlier date as may be required by applicable law;

 

   (ii)              any earned but unpaid Annual Performance Bonus for the calendar year preceding the Termination Date, paid at the time set forth in Section 3(b) above, or on such earlier date as may be required by applicable law;

 

   (iii)            subject to Section 3(f) above, any accrued but unused vacation time, paid subject to and in accordance with Company policy;

 

   (iv)            subject to Section 3(g) above, reimbursement for any unreimbursed business expenses incurred through the Termination Date, paid within sixty (60) calendar days following the Termination Date, or on such earlier date as may be required by applicable law; and

 

    (v)            all other payments and benefits to which the Executive is then entitled under the terms of any employee benefit plan of the Company, paid or provided subject to and in accordance with the terms of such plan.

 

10 


(b)              TERMINATION WITHOUT CAUSE; RESIGNATION FOR GOOD REASON. In the event that the Executive’s employment and the Employment Term end in accordance with Section 4(d) or 4(e), the Executive (or the Executive’s estate, as applicable) shall be entitled to the Accrued Benefits and, conditioned on the Executive’s (x) compliance with the “Release Condition” in Section 5(d) below and (y) continued compliance with Section 6 below, the Executive will earn and receive the following additional payments, subject to Section 11 below:

 

    (i)              an amount equal to the Executive’s Base Salary for one (1) year, paid in a single lump sum in cash on the first regular Company payroll date next following the sixtieth (60th) calendar day following the Termination Date;

 

   (ii)              an amount equal to the Target Performance Bonus for the calendar year containing the Termination Date, paid in a single lump sum in cash on the first regular Company payroll date next following the sixtieth (60th) calendar day following the Termination Date; and

 

   (iii)             subject to the Executive’s (x) eligibility for and timely election of continuation coverage under the Consolidated Omnibus Budget Reconciliation Act of 1985 (“COBRA”) and (y) continued copayment of coverage premiums at the same level and cost to the Executive as if the Executive were an employee of the Company (excluding, for purposes of calculating cost, an employee’s ability to pay premiums with pre-tax dollars), continued copayment by the Company for such coverage during the twelve (12)-month period following the Termination Date to the same extent that the Company paid for such coverage immediately prior to the Termination Date, in a manner intended to avoid any excise tax under Section 4980D of the Internal Revenue Code of 1986, as amended (the “Code”), and subject to the eligibility requirements and other terms and conditions of such insurance coverage.

 

(c)               TREATMENT OF EQUITY AWARDS. The treatment of the LTI Award, each Outperformance Award, and any other equity or equity-based award held by the Executive upon any termination of the Executive’s employment hereunder will be subject to the documents and agreements governing such awards.

 

(d)              RELEASE CONDITION. The Executive will be eligible to receive the payments and benefits described in Section 5(b) only if the Executive executes and delivers to the Company a general release of claims substantially in the form attached hereto as Exhibit B (the “General Release”), and such General Release becomes effective and irrevocable according to its terms, no later than sixty (60) calendar days following the Termination Date, and only so long as the Executive has not revoked or breached any of the provisions of the General Release and does not subsequently breach any such provisions (the “Release Condition”). To the extent that any amount under Section 5(b) constitutes “deferred compensation” for purposes of Section 409A of the Code, any payment of such amount scheduled to occur during the first sixty (60) calendar days following the Termination Date will not be made until the Company’s first regularly scheduled pay period next following the sixtieth (60th) calendar day after the Termination Date and will include payment of all amounts that were otherwise scheduled to be paid prior thereto.

 

(e)               EXCLUSIVE REMEDY. The payments and benefits described in this Section 5 will be in full and complete satisfaction of the Executive’s rights and entitlements under this Agreement and any other claims that Executive may have in respect of the Executive’s employment with the Company or any of its affiliates, and the termination thereof, and the Executive acknowledges that such amounts are fair and reasonable, and are the Executive’s sole and exclusive remedy, in lieu of all other remedies at law or in equity, with respect to the termination of the Executive’s employment hereunder or any breach of this Agreement. As of the date of the final payment described in this Section 5, the Company and its affiliates shall not have any further obligation to Executive under this Agreement or otherwise, except as may be required by law. Notwithstanding any language contained herein, Executive retains and does not waive any rights, claims and causes of actions that Executive may have as a shareholder of the Company.

 

11 


(f)               NO MITIGATION. In no event will the Executive be obligated to seek other employment or take any other action by way of mitigation of the amounts payable to the Executive under any of the provisions of this Agreement, and such amounts will not be reduced whether or not the Executive obtains other employment.

 

6.                RESTRICTIVE COVENANTS AND INVENTIONS ASSIGNMENT.

 

(a)               CONFIDENTIALITY.

 

    (i)              Executive agrees that during the course of employment with the Company, Executive has and will come into contact with and learn various forms of “Confidential Information” (as defined below), which are the property of the Company. For purposes of this Agreement, “Confidential Information” means items of information relating to the Company, its products, services, customers, suppliers, vendors, business partners, and employees that are not generally known or available to the general public, but have been developed, compiled or acquired by the Company at its great effort and expense. Confidential Information includes but is not limited to: (i) financial and business information, such as information with respect to costs, fees, profits, sales, margins, capital structure, operating results, borrowing arrangements, business strategy, plans for future business, pending projects and proposals, and potential acquisitions or divestitures; (ii) product and technical information, such as product formulations, new and innovative product ideas, investigations, new business development, know-how, improvements, plans, drawings, prototypes, methods, procedures, devices, machines, equipment, data processing programs, program documentation, algorithms, software, software codes, source codes, object codes, computer models, and research and development projects; (iii) marketing information, such as new marketing ideas, markets, mailing lists, the identity of the Company’s customers, their names and addresses, the names of representatives of the Company’s customers responsible for entering into contracts with the Company, the financial arrangements between the Company and such customers, specific customer needs and requirements, and leads and referrals to prospective customers; (iv) vendor, supplier and other business partner (collectively, the “Business Partners”) information, such as the identity of the Company’s Business Partners, their names and addresses, the names of representatives of the Company’s Business Partners responsible for entering into contracts with the Company, the financial arrangements between the Company and such Business Partners, their specific needs and requirements, and leads and referrals to prospective Business Partners; (v) personnel information, such as the identity and number of the Company’s other employees, consultants and contractors, their salaries, bonuses, benefits, skills, qualifications, and abilities (information described in this clause (v) is referred to as “Personnel Information”); and (vi)     trade secrets, as defined by applicable law. Confidential Information can be in any form: oral, written or machine readable, including electronic files. The absence of any marking or statement that any particular information is Confidential Information shall not affect its status as Confidential Information.

 

12 


    (ii)            Executive acknowledges and agrees that the Company is engaged in a highly competitive business and that its competitive position depends upon its ability to maintain the confidentiality of the Confidential Information which were developed, compiled and acquired by the Company at its great effort and expense. Executive further acknowledges and agrees that disclosing, divulging, revealing or using any of the Confidential Information, other than in connection with the Company’s business or as specifically authorized by the Company, will be highly detrimental to the Company, and that serious loss of business and pecuniary damage may result therefrom.

 

   (iii)            Accordingly, Executive agrees, except as specifically required in the performance of Executive’s duties on behalf of the Company, Executive will not, while associated with the Company and for so long thereafter as the pertinent information or documentation remains confidential, directly or indirectly disclose or disseminate to any other person, organization or entity or use any Confidential Information. Nothing contained in this Agreement is intended to prohibit Executive from discussing Personnel Information with other Company employees. Additionally, nothing contained in this Agreement prohibits or prevents Executive from filing a charge with or participating, testifying, or assisting in any investigation, hearing, whistleblowing proceeding or other proceeding before any federal, state, or local government agency (e.g., EEOC, NLRB, etc.). Under the federal Defend Trade Secrets Act of 2016, Executive shall not be held criminally or civilly liable under any federal or state trade secret law for the disclosure of a trade secret that: (a) is made (i) in confidence to a federal, state, or local government official, either directly or indirectly, or to an attorney; and (ii) solely for the purpose of reporting or investigating a suspected violation of law; or (b) is made to Executive’s attorney in relation to a lawsuit for retaliation against Executive for reporting a suspected violation of law; or (c) is made in a complaint or other document filed in a lawsuit or other proceeding, if such filing is made under seal.

 

    (iv)              Executive agrees to deliver to the Company, immediately upon the Executive’s Termination Date and at any other time the Company so requests: (i) any and all documents, files, notes, memoranda, databases, computer files and/or other computer programs reflecting any Confidential Information whatsoever or otherwise relating to the Company’s business; (ii) lists of the Company’s customers and leads or referrals to prospective customers; and (iii) any computer equipment, home office equipment, automobile or other business equipment belonging to the Company that Executive may then possess or have under Executive’s control. For any equipment or devices owned by Executive on which proprietary information of the Company is stored or accessible, Executive shall, immediately upon or prior to the Executive’s Termination Date, deliver such equipment or devices to the Company so that any proprietary information may be deleted or removed. Executive expressly authorizes the Company’s designated representatives to access such equipment or devices for this limited purpose and shall provide any passwords or access codes necessary to accomplish this task.

 

13 


(b)               NONCOMPETITION.

 

   (i)              Executive acknowledges and agrees that the Company is engaged in a highly competitive and global business, and that by virtue of Executive’s position and responsibilities with the Company and Executive’s access to the Confidential Information, engaging in a business which is directly competitive with the Company will cause it great and irreparable harm.

 

    (ii)           Accordingly, Executive covenants and agrees that for so long as Executive is employed by the Company and for a period of twelve (12) months after employment with the Company ends for any reason, whether voluntarily or involuntarily, Executive will not, directly or indirectly, own, manage, operate, control, be employed by (whether as an employee, consultant, independent contractor or otherwise, and whether or not for compensation) or render services to any person, firm, corporation or other entity, in whatever form, engaged in competition with the Company or any of its subsidiaries or affiliates or in any other material business in which the Company or any of its subsidiaries or affiliates is engaged on the Termination Date or in which they have planned, on or prior to such date, to be engaged in on or after such date. In recognition of the global nature of the Company’s business which includes the sale of its products and services globally, this restriction shall apply throughout the United States of America and such other countries where the Company is conducting business as of the Executive’s Termination Date.

 

   (iii)            Notwithstanding the foregoing, nothing herein will prohibit Executive from being a passive owner of not more than one percent (1%) of the equity securities of a publicly traded corporation engaged in a business that is in competition with the Company or any of its subsidiaries or affiliates, so long as the Executive has no active participation in the business of such corporation.

 

(c)               NONSOLICITATION; NONINTERFERENCE.

 

    (i)             Executive acknowledges and agrees that solely by reason of employment by the Company, and in light of the broad responsibilities of such employment: (x) Executive has and will come into contact with some, most or all of the Company’s customers and prospective customers, and will have access to Confidential Information regarding the Company’s customers, prospective customers and related information, including but not limited to information regarding customer contacts and representatives, customer needs and requirements, and financial arrangements with customers, and will have access to and the benefit of goodwill developed by the Company with its customers; (y) Executive has and will come into contact with and acquire Confidential Information regarding other employees, contractors and consultants of the Company, and will develop relationships with those employees, contractors and consultants; and (z) Executive has and will come into contact with and acquire Confidential Information regarding Business Partners, and will develop relationships with those Business Partners.

 

14 


   (ii)             Accordingly, Executive covenants and agrees that for so long as Executive is employed by the Company and for a period of two (2) years after employment with the Company ends for any reason, whether voluntarily or involuntarily, Executive will not, either on Executive’s own account or on behalf of any person, company or entity, except in the furtherance of Executive’s duties hereunder, directly or indirectly: (x) service or solicit customers or prospective customers of the Company for the purpose of selling products and services of the type developed, sold and provided by the Company; or (y) solicit, aid or induce any customer or prospective customer of the Company to purchase goods or services then sold by the Company from another person, firm, corporation or other entity, or assist or aid any other persons or entity in identifying or soliciting any such customer or prospective customer. This restriction shall apply only to those customers or prospective customers of the Company with whom Executive had contact or about whom Executive learned Confidential Information during the last two (2) years of Executive’s employment with the Company. For the purposes of this Section, the Parties agree that the term “contact” means interaction between Executive and the customer which takes place to further the business relationship, or making sales to or performing services for the customer on behalf of the Company, and the term “customer” includes, without limitation, each exchange on which cryptocurrency is traded. For purposes of this Section, the term “contact” with respect to a “prospective” customer means interaction between Executive and a potential customer of the Company which takes place to obtain the business of the potential customer on behalf of the Company.

 

   (iii)            Accordingly, Executive covenants and agrees that for so long as Executive is employed by the Company and for a period of twenty four (24) months after employment with the Company ends for any reason, whether voluntarily or involuntarily, Executive will not, either on Executive’s own account or on behalf of any person, company or entity, except in the furtherance of Executive’s duties hereunder, directly or indirectly, solicit any employee, contractor or consultant of the Company to leave employment with or service to the Company, or diminish their services to the Company. This restriction shall apply only to those employees, contractors and consultants of the Company with whom Executive came into contact or about whom Executive learned Confidential Information during the last two (2) years of Executive’s employment with the Company.

 

   (iv)           Accordingly, Executive covenants and agrees that for so long as Executive is employed by the Company and for a period of twenty four (24) months after employment with the Company ends for any reason, whether voluntarily or involuntarily, Executive will not, either on Executive’s own account or on behalf of any person, company or entity, except in the furtherance of Executive’s duties hereunder, directly or indirectly, solicit any Business Partner of the Company to terminate or diminish its services to the Company. This restriction shall apply only to those Business Partners of the Company with whom Executive came into contact or about whom Executive learned Confidential Information during the last two (2) years of Executive’s employment with the Company.

 

15 


 

(d) CONFLICT OF INTEREST AND EXCLUSIVITY.

 

(i)           During employment with the Company, Executive may not use his position, influence, knowledge of Confidential Information or the Company’s assets for personal gain. A direct or indirect financial interest, including joint ventures in or with a supplier, vendor, customer or prospective customer, without disclosure and the express written approval of the Board is prohibited during employment with the Company.

 

(ii)          In order to protect the Company’s Confidential Information, Executive agrees that, while employed by the Company, Executive shall not become employed by or involved in any way whatsoever, directly or indirectly, with any company, business or person that competes with the Company in any way whatsoever, directly or indirectly.

 

(iii)         Subject to the other provisions of this Section 6, it is expressly agreed and understood that Executive also works for and/or provides services to Brookstone Partners, and such of its subsidiaries, affiliates and related companies as Executive has disclosed to the Board in writing and the Board has approved as set forth in Exhibit D herein (the “Other Services”). Executive will continue to provide the Other Services on a limited basis, provided that the Other Services do not, individually or in the aggregate, materially interfere with Executive’s duties, obligations and restrictions under this Agreement or create a potential business or fiduciary conflict, in each case as determined by the Board in its sole and absolute discretion, provided however, that the Board shall give Executive thirty (30) calendar days’ notice to cure any determination made by the Board that the Other Services create a potential business or fiduciary conflict where, in the Board’s reasonable determination, such potential business or fiduciary conflict is susceptible to cure. Provided further that Executive will immediately notify the Board in writing in the event that the Other Services create, or may reasonably be expected to create, any material interference with his duties, obligations and restrictions under this Agreement or any potential business or fiduciary conflict. Any change in the Other Services (other than a complete cessation of any of the Other Services) after the Effective Date requires disclosure by Executive and approval by the Board as set forth in the first sentence of this paragraph.

 

(e) NONDISPARAGEMENT.

 

Executive agrees not to make negative comments or otherwise disparage the Company or its officers, directors, employees, shareholders, agents or products other than in the good faith performance of the Executive’s duties to the Company while the Executive is employed by the Company. The foregoing will not be violated by truthful statements in response to legal process, required governmental testimony or filings, or administrative or arbitral proceedings.

 

The Company will instruct the Board and its senior management not to make negative comments or otherwise disparage the Executive to any third parties, other than in the good faith performance of their duties to the Company. The foregoing will not be violated by truthful statements in response to legal process, required governmental testimony or filings, or administrative or arbitral proceedings.

 

16 


 

(f) INVENTIONS ASSIGNMENT.

 

(i)            Executive acknowledges and agrees that all ideas, methods, inventions, discoveries, improvements, products, designs, specifications, developments, software, know-how, negative know-how, processes, techniques, methods, works of authorship and other work product, whether patentable or unpatentable, (A) that are reduced to practice, created, invented, designed, developed, contributed to, or improved with the use of any Company resources and/or within the scope of Executive’s work with the Company or that relate to the business, operations or actual or demonstrably anticipated research or development of the Company, and that are made or conceived by Executive, solely or jointly with others, during the Employment Term, or (B) suggested by any work that Executive performs in connection with the Company, will belong exclusively to the Company (or its designee), whether or not patent or other applications for intellectual property protection are filed thereon (the “Inventions”).

 

(ii)           Executive will keep full and complete written records (the “Records”), in the manner prescribed by the Company, of all Inventions, and will promptly disclose all Inventions completely and in writing to the Company. The Records will be the sole and exclusive property of the Company, and Executive will surrender them upon the termination of the Employment Term, or upon the Company’s request. Executive irrevocably conveys, transfers and assigns to the Company the Inventions and all patents or other intellectual property rights that may issue thereon in any and all countries, whether during or subsequent to the Employment Term, together with the right to file, in Executive’s name or in the name of the Company (or its designee), applications for patents and equivalent rights (the “Applications”). Executive will, at any time during and subsequent to the Employment Term, make such applications, sign such papers, take all rightful oaths, and perform all other acts as may be requested from time to time by the Company to perfect, record, enforce, protect, patent or register the Company’s rights in the Inventions, all without additional compensation to Executive from the Company. Executive will also execute assignments to the Company (or its designee) of the Applications, and give the Company and its attorneys all reasonable assistance (including the giving of testimony) to obtain the Inventions for the Company’s benefit, all without additional compensation to Executive from the Company.

 

(iii)          In addition, the Inventions will be deemed Work for Hire, as such term is defined under the copyright laws of the United States, on behalf of the Company, and Executive agrees that the Company will be the sole owner of the Inventions, and all underlying rights therein, in all media now known or hereinafter devised, throughout the universe and in perpetuity without any further obligations to Executive. If the Inventions, or any portion thereof, are deemed not to be Work for Hire, or the rights in such Inventions do not otherwise automatically vest in the Company, Executive hereby irrevocably conveys, transfers and assigns to the Company, all rights, in all media now known or hereinafter devised, throughout the universe and in perpetuity, in and to the Inventions, including, without limitation, all of Executive’s right, title and interest in the copyrights (and all renewals, revivals and extensions thereof) to the Inventions, including, without limitation, all rights of any kind or any nature now or hereafter recognized, including, without limitation, the unrestricted right to make modifications, adaptations and revisions to the Inventions, to exploit and allow others to exploit the Inventions and all rights to sue at law or in equity for any infringement, or other unauthorized use or conduct in derogation of the Inventions, known or unknown, prior to the date hereof, including, without limitation, the right to receive all proceeds and damages therefrom. In addition, Executive hereby waives any so-called “moral rights” with respect to the Inventions. Executive hereby waives any and all currently existing and future monetary rights in and to the Inventions and all patents and other registrations for intellectual property that may issue thereon, including, without limitation, any rights that would otherwise accrue to Executive’s benefit by virtue of Executive being an employee of or other service provider to the Company.

  

17 


 

(iv)         Executive further covenants and agrees that the Company shall be entitled to shop rights with respect to any Inventions conceived or made by Executive during employment with the Company, which were conceived or made on the Company’s time or with the use of the Company’s facilities or materials.

  

(v)          Executive covenants and agrees that Executive will obtain the written consent of the Board in advance of any presentation or publication, or submission for presentation or publication, of any speech, paper or article authored by Executive, either alone or jointly with others. Executive further covenants and agrees that it shall be conclusively presumed as against Executive that any Inventions described by Executive in a patent, service mark, trademark, or copyright application, disclosed by Executive in any manner to a third person, or created by Executive or any person with whom Executive has any business, financial or confidential relationship, within twelve (12) months after the Executive’s Termination Date, were conceived or made by Executive during the Employment Term and that such Inventions are the sole property of the Company.

  

(vi)         Exhibit C to this Agreement fully describes all inventions developed by Executive alone or jointly with others before being employed by the Company (“Prior Inventions”), and which are, therefore, not part of this Agreement. If no separate sheet is attached, the parties acknowledge that there exist no such Prior Inventions. If in the course of employment with the Company, Executive incorporates into a Company product, process or service a Prior Invention owned by Executive or in which Executive has an interest, Executive hereby grants to the Company a nonexclusive, royalty-free, fully paid-up, irrevocable, perpetual, worldwide license to make, have made, modify, use and sell such Prior Invention as part of or in connection with such product, process or service, and to practice any method related thereto.

  

18 


 

(vii)        Notwithstanding anything above, these invention assignment provisions do not apply to an invention for which no equipment, supplies, facility, or trade secret information of the Company was used and which was developed entirely on the Executive’s own time, unless (a) the invention relates (i) to the business of the Company, or (ii) to the Company's actual or demonstrably anticipated research or development, or (b) the invention results from, or is derivative of, any work performed by the Executive for the Company.

  

(g)           COOPERATION. Upon the receipt of reasonable notice from the Company (including its outside counsel), Executive agrees that, while employed by the Company and thereafter, Executive will respond and provide information with regard to matters in which Executive has knowledge as a result of Executive’s employment with the Company, and will provide reasonable assistance to the Company, its affiliates and their respective representatives in defense of any claims that may be made against the Company or its affiliates, and will assist the Company and its affiliates in the prosecution of any claims that may be made by the Company or its affiliates, to the extent that such claims may relate to the period of Executive’s employment with the Company (collectively, the “Claims”). Executive agrees to promptly inform the Company if Executive becomes aware of any lawsuits involving Claims that may be filed or threatened against the Company or its affiliates. Executive also agrees to promptly inform the Company (to the extent that Executive is legally permitted to do so) if Executive is asked to assist in any investigation of the Company or its affiliates (or their actions) or another party attempts to obtain information or documents from Executive (other than in connection with any litigation or other proceeding in which the Executive is a party-in-opposition) with respect to matters the Executive believes in good faith to relate to any investigation of the Company or its affiliates, in each case, regardless of whether a lawsuit or other proceeding has then been filed against the Company or its affiliates with respect to such investigation, and will not do so unless legally required. During the pendency of any litigation or other proceeding involving Claims, Executive will not communicate with anyone (other than Executive’s attorneys and tax and/or financial advisors, except to the extent that Executive determines in good faith is necessary in connection with the performance of Executive’s duties hereunder, and as required by law) with respect to the facts or subject matter of any pending or potential litigation or regulatory or administrative proceeding involving the Company or any of its affiliates without giving prior written notice to the Company or the Company’s counsel. Upon presentation of appropriate documentation, the Company will pay or reimburse the Executive for all reasonable out-of-pocket travel, duplicating or telephonic expenses incurred by the Executive in complying with this Section 6(g).

 

(h) ENFORCEMENT.

 

(i)           Executive acknowledges and agrees that compliance with the covenants set forth in this Agreement is necessary to protect the Confidential Information, business and goodwill of the Company, and that any breach of this Agreement will result in irreparable and continuing harm to the Company, for which money damages cannot provide adequate relief. Accordingly, in the event of any breach or anticipatory breach of this Agreement by Executive, the Parties agree that the Company shall be entitled to injunctions, both preliminary and permanent, enjoining or restraining such breach or anticipatory breach, and Executive hereby consents to the issuance thereof forthwith and without bond by any court of competent jurisdiction. Executive covenants that Executive will not challenge the reasonableness or enforceability of any of the covenants in this Agreement. In addition, in the event of any proceeding or similar action pertaining to an alleged breach or anticipatory breach by the Executive of this Agreement, including any grant of temporary, preliminary, or permanent injunctive relief, or Executive’s claim in a declaratory judgment action that all or part of this Agreement is unenforceable, the Parties agree that the prevailing Party, as determined by a final non-appealable decision of the arbitrator or court of competent jurisdiction presiding over such proceeding or action, shall be entitled to recovery of all of its reasonable attorneys’ fees incurred in defending or seeking to enforce the provisions of this Agreement, in addition to any remedies otherwise available to it at law or equity.

 

 

19 


 

(ii) In the event the Board reasonably determines that Executive has violated Section 6, any severance being paid to the Executive pursuant to this Agreement or otherwise (other than the Accrued Benefits) will immediately cease, and, in the event of a final nonappealable decision by a court of competent jurisdiction or arbitrator (as applicable) that Executive has violated Section 6, any severance (other than the Accrued Benefits) previously paid to the Executive will be immediately repaid to the Company.

 

(i)            REFORMATION. If it is determined by a court of competent jurisdiction in any state or an arbitral tribunal that any restriction in this Section 6 is excessive in duration or scope or is unreasonable or unenforceable under applicable law, it is the intention of the Parties that such restriction may be modified or amended by the court or tribunal to render it enforceable to the maximum extent permitted by the laws of that state.

 

(j)            TOLLING. In the event of any violation of the provisions of this Section 6, Executive acknowledges and agrees that the post-termination restrictions contained in this Section 6 will be extended by a period of time equal to the period of such violation, it being the intention of the Parties hereto that the running of the applicable post-termination restriction period will be tolled during any period of such violation.

 

(k)           DISCLOSURE OF AGREEMENT; DISCLOSURE OF NEW EMPLOYMENT. Executive covenants and agrees that Executive will promptly disclose the existence of this Agreement and the post-employment restrictions contained herein to all subsequent employers until all such covenants have expired. Executive further covenants and agrees that Executive will promptly inform the Company in writing of all employment or business ventures in which Executive becomes engaged (other than employment by the Company or performance of Other Services, subject to the disclosure requirements of Section 6(d)(iii)) until all post-employment restrictions contained herein expire.

 

(l)            CONFIDENTIAL INFORMATION BELONGING TO OTHERS. Executive affirms Executive is not presently subject to a restrictive covenant or other contract or agreement of any kind which would prohibit, restrict or limit Executive’s employment with the Company. If Executive learns or becomes aware or is advised that Executive is subject to an actual or alleged restrictive covenant or other prior agreement which may prohibit or restrict Executive’s employment by the Company, Executive shall immediately notify the Company of the same. Executive agrees that Executive shall not disclose to the Company, use for the Company’s benefit, or induce the Company to use, any trade secret or confidential information Executive may possess or any intellectual property belonging to any former employer or other third party.

 

20 


 

(m)          AFFILIATES, SUBSIDIARIES AND RELATED COMPANIES. All references to the “Company” in this Section 6 shall also include the Company’s affiliates, subsidiaries and related companies.

 

7.   ARBITRATION. Any dispute or controversy arising under or in connection with this Agreement or Executive’s employment with the Company, other than injunctive relief, will be settled exclusively by arbitration, conducted before a single arbitrator in the County where the Company’s principal business offices are located in accordance with the National Rules for the Resolution of Employment Disputes of the American Arbitration Association then in effect. The decision of the arbitrator will be final and binding upon the parties hereto. Judgment may be entered on the arbitrator’s award in any court having jurisdiction. The Parties acknowledge and agree that in connection with any such arbitration and regardless of outcome, (i) each Party will pay all of its own costs and expenses, including, without limitation, its own legal fees and expenses, and (ii) the arbitration costs will be shared equally by the Parties, but the arbitrator in its sole discretion may award the prevailing party all or a portion of its share of the arbitration costs. The arbitrator shall apply the substantive law of the State of New York, without regard to its conflicts of laws principles.

 

8. INDEMNIFICATION; D&O COVERAGE.

 

(a)           The Company will indemnify the Executive to the full extent required under the Company’s Certificate of Incorporation and By-Laws, and under applicable law.

 

(b)           The Company will maintain a directors’ and officers’ liability insurance policy (or policies) providing coverage for the Executive that is no less favorable to him in any respect (including as to the length of any post-employment tail coverage) than the coverage then being provided to any other officer or director of the Company.

 

9.             NO ASSIGNMENTS. This Agreement is personal to each of the parties hereto. Except as provided in this paragraph, no party may assign or delegate any rights or obligations hereunder without first obtaining the written consent of the other party hereto. The Company may assign this Agreement to any successor to all or substantially all of the business and/or assets of the Company. As used in this Agreement, “Company” will mean the Company and any successor to its business and/or assets, which assumes and agrees to perform the duties and obligations of the Company under this Agreement by operation of law or otherwise.

 

21 


 

10.          NOTICE. All notices, demands or other communications to be given or delivered under or by reason of the provisions of this Agreement will be in writing and will be deemed to have been given when delivered personally, the third Business Day after having been mailed by certified or registered mail, return receipt requested and postage prepaid, or the first Business Day after the date sent via a nationally recognized overnight courier. “Business Day” is any day other than a Saturday, Sunday or a day on which banks in New York are required or authorized to be closed. Such notices, demands and other communications will be sent to the address indicated below:

 

If to the Executive:

 

At the Executive’s address (or to the facsimile number) shown in the books and records of the Company.

 

If to the Company:

 

Soluna Holdings, Inc.
Attention: Board of Directors 

325 Washington Avenue Extension
Albany, NY 12205

 

With a copy (which will not constitute notice) to:

 

Jackson Lewis P.C. 

Attention: Kenneth C. Weafer, Attorney at Law 

677 Broadway, 9th Floor Albany, 

NY 12207

 

or to such other address as either Party may have furnished to the other in writing in accordance herewith, except that notices of change of address will be effective only upon receipt.

 

11. TAX MATTERS.

 

(a)           WITHHOLDING. The Company may withhold from any compensation and benefits payable under this Agreement all applicable federal, state, local, or other taxes, and any other applicable withholdings.

 

(b) SECTION 409A.

 

(i)             The Parties intend for payments and benefits hereunder to either comply with, or be exempt from, Section 409A of the Code and the regulations promulgated thereunder (collectively “Section 409A”) and, accordingly, to the maximum extent permitted, this Agreement will be interpreted and construed consistent with such intent. To the extent that any provision hereof is modified in order to comply with Section 409A, such modification will be made in good faith and will, to the maximum extent reasonably possible, maintain the original intent and economic benefit to the Executive and the Company of the applicable provision without violating the provisions of Section 409A. Notwithstanding the foregoing, the Company does not guarantee any particular tax result, and in no event whatsoever will the Company, its affiliates, or their respective officers, directors, employees, counsel or other service providers be liable for any tax, interest or penalty that may be imposed on the Executive by Section 409A or damages for failing to comply with Section 409A.

 

22 


 

(ii)           To the extent that reimbursements or other in-kind benefits hereunder constitute “deferred compensation” for purposes of Section 409A, (x) all expenses or other reimbursements hereunder will be made on or prior to the last day of the taxable year following the taxable year in which such expenses were incurred by the Executive, (y) any right to reimbursement or in-kind benefits will not be subject to liquidation or exchange for another benefit, and (z) no such reimbursement, expenses eligible for reimbursement, or in-kind benefits provided in any taxable year will in any way affect the expenses eligible for reimbursement, or inkind benefits to be provided, in any other taxable year.

 

 

(iii)           For purposes of Section 409A, the Executive’s right to receive installment payments pursuant to this Agreement shall be treated as a right to receive a series of separate and distinct payments. Whenever a payment hereunder specifies a payment period with reference to a number of days, the actual date of payment within the specified period shall be within the sole discretion of the Company.

 

(iv)          Any other provision of this Agreement to the contrary notwithstanding, in no event will any payment or benefit hereunder that constitutes “deferred compensation” for purposes of Section 409A be subject to offset by any other amount unless otherwise permitted by Section 409A.

 

(v)           A termination of employment will not be deemed to have occurred for purposes of any provision of this Agreement providing for the payment of any amounts or benefits upon or following a termination of employment unless such termination is also a “separation from service” within the meaning of Section 409A, and, for purposes of any such provision, all references in this Agreement to the Executive’s “termination”, “termination of employment” and like terms will mean the Executive’s “separation from service” with the Company.

 

(vi)          Notwithstanding any other provision of this Agreement to the contrary, if, at the time of the Executive’s separation from service, the Executive is a “Specified Employee”, then the Company will defer the payment or commencement of any nonqualified deferred compensation subject to Section 409A payable upon separation from service (without any reduction in such payments or benefits ultimately paid or provided to the Executive) until the date that is six (6) months following separation from service or, if earlier, the earliest other date as is permitted under Section 409A (and any amounts that otherwise would have been paid during this deferral period will be paid in a lump sum on the day after the expiration of the six (6) month period or such shorter period, if applicable). The Executive will be a “Specified Employee” for purposes of this Agreement if, on the date of the Executive’s separation from service, the Executive is an individual who is, under the method of determination adopted by the Company, designated as, or within the category of employees deemed to be, a “Specified Employee” within the meaning and in accordance with Treasury Regulation Section 1.409A-1(i). The Board will determine in its sole discretion all matters relating to who is a “Specified Employee” and the application of and effects of the change in such determination.

 

23 


 

(c)           SECTION 280G. In the event that any payments and other benefits provided for in this Agreement or otherwise payable to the Executive constitute “parachute payments” within the meaning of Section 280G of the Code, and, but for this paragraph, would be subject to the excise tax imposed by Section 4999 of the Code, then any post-termination severance payments and benefits payable under this Agreement or otherwise will be either (1) delivered in full or (2) delivered as to such lesser extent which would result in no portion of such payments and benefits being subject to excise tax under Section 4999 of the Code, whichever of the foregoing amounts, taking into account the applicable federal, state and local income taxes and the excise tax imposed by Section 4999 of the Code, results in the receipt by the Executive, on an after-tax basis, of the greatest amount of payments and benefits, notwithstanding that all or some portion of such benefits may be taxable under Section 4999 of the Code. If a reduction in the Executive’s payments and benefits is necessitated by the preceding sentence, such reduction will occur in the following order: (i) any cash severance based on a multiple of base salary or annual bonus, (ii) any other cash amounts payable to the Executive, (iii) benefits valued as parachute payments, and (iv) acceleration of vesting of any equity awards. Unless the Company and the Executive otherwise agree in writing, any determination required under this paragraph will be made in writing by the Company’s independent public accountants (the “Firm”), whose determination will be conclusive and binding upon the Executive and the Company. For purposes of making the calculations required by this paragraph, the Firm may make reasonable assumptions and approximations concerning applicable taxes and may rely on reasonable, good faith interpretations concerning the application of Sections 280G and 4999 of the Code. The Company and the Executive will furnish to the Firm such information and documents as the Firm may reasonably request in order to make a determination under this paragraph. The Company will bear all costs the Firm may incur in connection with any calculations contemplated by this paragraph. 

 

12.          CLAWBACK. All amounts paid or provided to the Executive hereunder shall be subject to any clawback or recoupment policy that may be maintained by the Company from time to time pursuant to any legal or listing requirement, or that is otherwise generally applicable to the Company’s officers or executives, and/or the requirements of any law or regulation applicable to the Company governing the clawback or recoupment of executive compensation. Without limiting the foregoing, in the event that the Company determines that it is required to prepare an accounting restatement due to a material noncompliance with any financial reporting requirement under the applicable securities laws, the Company may require the Executive to, and the Executive agrees to, return or repay to the Company any Outperformance Award previously paid or provided to the Executive that would not have been paid or provided based on the accounting restatement, as determined by the Company in its sole and absolute discretion.

 

13.          GOVERNING LAW. This Agreement, the rights and obligations of the Parties hereto, and any claims or disputes relating thereto, will be governed by and construed in accordance with the laws of the State of New York, without regard to its conflicts of laws principles. The Parties agree that any claims or disputes not subject to arbitration under Section 7 will be subject to the exclusive jurisdiction of the courts residing in the County of Albany, State of New York, and the Parties waive any objection to the venue or jurisdiction of any such courts, as well as their respective rights to have any such claims or disputes heard before a jury or an advisory jury.

 

24 


 

14. MISCELLANEOUS.

 

(a)           SURVIVAL. Sections 2, 5 and 6 through 14 hereof will survive and continue in full force and effect in accordance with their respective terms notwithstanding any expiration or termination of the Employment Term and/or this Agreement.

 

(b)           MODIFICATION; WAIVER. No provision of this Agreement may be modified, waived or discharged unless such modification, waiver or discharge is agreed to in writing and signed by the Executive and such officer or director of the Company as may be designated by the Board. No waiver by either Party hereto at any time of any breach by the other Party hereto of, or compliance with, any condition or provision of this Agreement to be performed by such other Party will be deemed a waiver of similar or dissimilar provisions or conditions at the same or at any prior or subsequent time. This Agreement, together with all exhibits hereto, sets forth the entire agreement of the Parties hereto in respect of the subject matter contained herein and supersedes any and all prior agreements or understandings between the Executive and the Company with respect to the subject matter hereof. No agreements or representations, oral or otherwise, express or implied, with respect to the subject matter hereof have been made by either Party which are not expressly set forth in this Agreement.

 

(c)           EXECUTIVE’S REPRESENTATION. The Executive represents and warrants to the Company that the Executive has the legal right to enter into this Agreement and to perform all of the obligations on the Executive’s part to be performed hereunder in accordance with its terms.

 

(d)           SECTION HEADINGS. The section headings used in this Agreement are included solely for convenience and will not affect, or be used in connection with, the interpretation of this Agreement.

 

(e)           SEVERABILITY. The provisions of this Agreement will be deemed severable. The invalidity or unenforceability of any provision of this Agreement in any jurisdiction will not affect the validity, legality or enforceability of the remainder of this Agreement in such jurisdiction or the validity, legality or enforceability of any provision of this Agreement in any other jurisdiction, it being intended that all rights and obligations of the Parties hereunder will be enforceable to the fullest extent permitted by applicable law.

 

(f)            COUNTERPARTS. This Agreement may be executed in several counterparts, each of which will be deemed to be an original but all of which together will constitute one and the same instrument. Facsimile, PDF, and electronic counterpart signatures to and versions of this Agreement will be acceptable and binding on the Parties.

 

[SIGNATURE PAGE FOLLOWS]

 

25 


 

IN WITNESS WHEREOF, the Parties hereto have executed this Agreement as of the date first written above.

 

  COMPANY
         
  By:     /s/ Thomas J. Marusak
         
  Name: Thomas J. Marusak
         
  Title:   Compensation Committee Chair
         
         
  EXECUTIVE
         
  /s/ Michael Toporek       
  Michael Toporek

 

26 


 

EXHIBIT A

 

ILLUSTRATIVE EXAMPLES FOR SECTION 3(d)

 

(See Attached Excel Spreadsheet entitled “Exhibit A Outperformance Award 010522”)

 

A-1 


 

EXHIBIT B

 

GENERAL RELEASE

 

I, Michael Toporek, in consideration of and subject to the performance by Soluna Holdings, Inc. (together with its affiliates, the “Company”), of its obligations under the Employment Agreement dated as of [DATE], (the “Agreement”), do hereby release and forever discharge as of the date hereof the Company and its respective affiliates and all present, former and future managers, directors, officers, employees, successors and assigns of the Company and its affiliates and direct or indirect owners (collectively, the “Released Parties”) to the extent provided below (this “General Release”). The Released Parties are intended to be third-party beneficiaries of this General Release, and this General Release may be enforced by each of them in accordance with the terms hereof in respect of the rights granted to such Released Parties hereunder. Terms used herein but not otherwise defined will have the meanings given to them in the Agreement.

 

1.             I understand that any payments or benefits paid or granted to me under Section 5(b) of the Agreement represent, in part, consideration for signing this General Release and are not salary, wages or benefits to which I was already entitled. I understand and agree that I will not receive the payments and benefits specified in Section 5(b) of the Agreement unless I execute this General Release and do not revoke this General Release within the time period permitted hereafter. Such payments and benefits will not be considered compensation for purposes of any employee benefit plan, program, policy or arrangement maintained or hereafter established by the Company or its affiliates.

 

2.             Except as provided in paragraphs 4 and 5 below and except for the provisions of the Agreement which expressly survive the termination of my employment with the Company, I knowingly and voluntarily (for myself, my heirs, executors, administrators and assigns) release and forever discharge the Company and the other Released Parties from any and all claims, suits, controversies, actions, causes of action, cross-claims, counter-claims, demands, debts, compensatory damages, liquidated damages, punitive or exemplary damages, other damages, claims for costs and attorneys’ fees, or liabilities of any nature whatsoever in law and in equity, both past and present (through the date that this General Release becomes effective and enforceable) and whether known or unknown, suspected, or claimed against the Company or any of the Released Parties which I, my spouse, or any of my heirs, executors, administrators or assigns, may have, which arise out of or are connected with my employment with, or my separation or termination from, the Company (including, but not limited to, any allegation, claim or violation, arising under: Title VII of the Civil Rights Act of 1964, as amended; the Civil Rights Act of 1991; the Age Discrimination in Employment Act of 1967, as amended (including the Older Workers Benefit Protection Act); the Equal Pay Act of 1963, as amended; the Americans with Disabilities Act of 1990; the Family and Medical Leave Act of 1993; the Worker Adjustment Retraining and Notification Act; the Employee Retirement Income Security Act of 1974; any applicable Executive Order Programs; the Fair Labor Standards Act; or their state or local counterparts; or under any other federal, state or local civil or human rights law, or under any other local, state, or federal law, regulation or ordinance; or under any public policy, contract or tort, or under common law; or arising under any policies, practices or procedures of the Company; or any claim for wrongful discharge, breach of contract, infliction of emotional distress, defamation; or any claim for costs, fees, or other expenses, including attorneys’ fees incurred in these matters) (all of the foregoing collectively referred to herein as the “Claims”).

 

B-1 


 

3.             I represent that I have made no assignment or transfer of any right, claim, demand, cause of action, or other matter covered by paragraph 2 above.

 

4.             I agree that this General Release does not waive or release any rights or claims that I may have under the Age Discrimination in Employment Act of 1967 which arise after the date I execute this General Release. I acknowledge and agree that my separation from employment with the Company in compliance with the terms of the Agreement will not serve as the basis for any claim or action (including, without limitation, any claim under the Age Discrimination in Employment Act of 1967).

 

5.             I agree that I hereby waive all rights to sue or obtain equitable, remedial or punitive relief from any or all Released Parties of any kind whatsoever in respect of any Claim, including, without limitation, reinstatement, back pay, front pay, and any form of injunctive relief. Notwithstanding the above, I further acknowledge that I am not waiving and am not being required to waive any right that cannot be waived under law, including the right to file an administrative charge or participate in an administrative investigation or proceeding; provided, however, that I disclaim and waive any right to share or participate in any monetary award resulting from the prosecution of such charge or investigation or proceeding. Additionally, I am not waiving (i) any right to the Accrued Benefits or any severance benefits to which I am entitled under the Agreement, (ii) any claim relating to directors’ and officers’ liability insurance coverage or any right of indemnification under the Company’s organizational documents or otherwise, or (iii) my rights as an equity or security holder in the Company or its affiliates.

 

6.             In signing this General Release, I acknowledge and intend that it will be effective as a bar to each and every one of the Claims hereinabove mentioned or implied. I expressly consent that this General Release will be given full force and effect according to each and all of its express terms and provisions, including those relating to unknown and unsuspected Claims (notwithstanding any state or local statute that expressly limits the effectiveness of a general release of unknown, unsuspected and unanticipated Claims), if any, as well as those relating to any other Claims hereinabove mentioned or implied. I acknowledge and agree that this waiver is an essential and material term of this General Release and that without such waiver the Company would not have agreed to the terms of the Agreement. I further agree that in the event I should bring a Claim seeking damages against the Company, or in the event I should seek to recover against the Company in any Claim brought by a governmental agency on my behalf, this General Release will serve as a complete defense to such Claims to the maximum extent permitted by law. I further agree that I am not aware of any pending claim of the type described in paragraph 2 above as of the execution of this General Release.

 

B-2 


 

7.             I agree that neither this General Release, nor the furnishing of the consideration for this General Release, will be deemed or construed at any time to be an admission by the Company, any Released Party or myself of any improper or unlawful conduct.

 

8.             I agree that if I violate this General Release by suing the Company or the other Released Parties, I will pay all costs and expenses of defending against the suit incurred by the Released Parties, including reasonable attorneys’ fees.

 

9.             I agree that this General Release and the Agreement are confidential and agree not to disclose any information regarding the terms of this General Release or the Agreement, except to my immediate family and any tax, legal or other counsel I have consulted regarding the meaning or effect hereof or as required by law, and I will instruct each of the foregoing not to disclose the same to anyone.

 

10.           Any non-disclosure provision in this General Release does not prohibit or restrict me (or my attorney) from responding to any inquiry about this General Release or its underlying facts and circumstances by the Securities and Exchange Commission (SEC), the Financial Industry Regulatory Authority (FINRA), any other self-regulatory organization or any governmental entity.

 

11.           I hereby acknowledge that Sections 2, 5 and 6 through 14 of the Agreement will survive my execution of this General Release.

 

12.           I represent that I am not aware of any claim by me other than the claims that are released by this General Release. I acknowledge that I may hereafter discover claims or facts in addition to or different than those which I now know or believe to exist with respect to the subject matter of the release set forth in paragraph 2 above and which, if known or suspected at the time of entering into this General Release, may have materially affected this General Release and my decision to enter into it.

 

13.           Notwithstanding anything in this General Release to the contrary, this General Release will not relinquish, diminish, or in any way affect any rights or claims arising out of any breach by the Company or by any Released Party of the Agreement after the date hereof.

 

14.           Whenever possible, each provision of this General Release will be interpreted in, such manner as to be effective and valid under applicable law, but if any provision of this General Release is held to be invalid, illegal or unenforceable in any respect under any applicable law or rule in any jurisdiction, such invalidity, illegality or unenforceability will not affect any other provision or any other jurisdiction, but this General Release will be reformed, construed and enforced in such jurisdiction as if such invalid, illegal or unenforceable provision had never been contained herein.

 

BY SIGNING THIS GENERAL RELEASE, I REPRESENT AND AGREE THAT:

 

1. I HAVE READ IT CAREFULLY;

 

2. I UNDERSTAND ALL OF ITS TERMS AND KNOW THAT I AM GIVING UP IMPORTANT RIGHTS, INCLUDING BUT NOT LIMITED TO, RIGHTS UNDER THE AGE DISCRIMINATION IN EMPLOYMENT ACT OF 1967, AS AMENDED, TITLE VII OF THE CIVIL RIGHTS ACT OF 1964, AS AMENDED; THE EQUAL PAY ACT OF 1963, THE AMERICANS WITH DISABILITIES ACT OF 1990; AND THE EMPLOYEE RETIREMENT INCOME SECURITY ACT OF 1974, AS AMENDED;

 

B-3 


 

3. I VOLUNTARILY CONSENT TO EVERYTHING IN IT;

 

4. I HAVE BEEN ADVISED TO CONSULT WITH AN ATTORNEY BEFORE EXECUTING IT AND I HAVE DONE SO OR, AFTER CAREFUL READING AND CONSIDERATION, I HAVE CHOSEN NOT TO DO SO OF MY OWN VOLITION;

 

5. I HAVE HAD AT LEAST [21][45] DAYS FROM THE DATE OF MY RECEIPT OF THIS RELEASE TO CONSIDER IT, AND THE CHANGES MADE SINCE MY RECEIPT OF THIS RELEASE ARE NOT MATERIAL OR WERE MADE AT MY REQUEST AND WILL NOT RESTART THE REQUIRED [21][45]- DAY PERIOD;

 

6. I UNDERSTAND THAT I HAVE SEVEN (7) DAYS AFTER THE EXECUTION OF THIS RELEASE TO REVOKE IT AND THAT THIS RELEASE SHALL NOT BECOME EFFECTIVE OR ENFORCEABLE UNTIL THE REVOCATION PERIOD HAS EXPIRED;

 

7. I HAVE SIGNED THIS GENERAL RELEASE KNOWINGLY AND VOLUNTARILY AND WITH THE ADVICE OF ANY COUNSEL RETAINED TO ADVISE ME WITH RESPECT TO IT; AND

 

8. I AGREE THAT THE PROVISIONS OF THIS GENERAL RELEASE MAY NOT BE AMENDED, WAIVED, CHANGED OR MODIFIED EXCEPT BY AN INSTRUMENT IN WRITING SIGNED BY AN AUTHORIZED REPRESENTATIVE OF THE COMPANY AND BY ME.

 

SIGNED:  /s/ Michael Toporek   DATED:  1/14/2022

  

B-4 


 

EXHIBIT C

 

PRIOR INVENTIONS

 

None

 

C-1 


 

EXHIBIT D

 

DISCLOSURE OF OTHER SERVICES

 

Executive is the President of Brookstone Partners IAC, which is the investment manager for Brookstone Partners’ investment portfolio companies. Such investment portfolio companies include: Brookstone Partners Acquisition XIV (Totalstone, D/B/A Instone), XIX (Denison Pharmaceuticals), XXI (Diamond Products), and XXIV (Soluna); Brookstone VAC (Virginia Abrasives); and Brookstone Remediation (Advanced DRI), as well as each of its/their related investment vehicles.

 

Executive is on the Board of Directors for each of the above companies identified above.

 

Executive is President of Capstone Therapeutics (stock ticker “CAPS”), which is a holding company for Brookstone Partners Acquisition XXI and XIV. This role requires a minor time investment of approximately 4-5 hours annually.

 

Executive, through his role at Brookstone Partners IAC, is the Manager for Terajoule (an investor in Soluna), and the Manager for Capital Matrix (an investor in Soluna, Harmattan, and two additional energy projects in Africa).

 

D-1 

EX-10.2 3 g082575_ex10-2.htm EXHIBIT 10.2

 

Exhibit 10.2

 

EMPLOYMENT AGREEMENT

 

This EMPLOYMENT AGREEMENT (this “Agreement”) between MTI Instruments, Inc., a New York corporation (the “Company”), and Moshe Binyamin (“Executive”) is effective as of the date of its execution (the “Effective Date”).

 

WHEREAS, Executive is currently employed by the Company as its President; and

 

WHEREAS, the Company desires to maintain the services of Executive, Executive desires to continue employment with the Company, and each desires to enter in an agreement to provide the terms of such employment as set forth herein.

 

NOW, THEREFORE, the parties agree as follows:

 

1.             Definitions. As used herein, the following terms shall have the following meanings:

 

“Board” means the Company’s Board of Directors.

 

“Cause” means any of the following: (i) Executive’s theft, dishonesty, fraud, embezzlement, willful misconduct, breach of fiduciary duty or material falsification of any Group Company documents or records; (ii) Executive’s material failure to abide by a Group Company’s code of conduct or other policies (including policies relating to confidentiality and reasonable workplace conduct) made available to the Executive; (iii) Executive’s unauthorized use, misappropriation, destruction or diversion of any tangible or intangible asset or corporate opportunity of a Group Company (including the Executive’s improper use or disclosure of a Group Company’s confidential or proprietary information); (iv) any misconduct, moral turpitude, gross negligence or malfeasance of Executive that has or, in the good faith judgment of the Board, could reasonably be expected to have, a material detrimental effect on a Group Company’s reputation or business; (v) Executive’s repeated willful failure to perform Executive’s assigned duties after written notice from the Board of such failure; (vi) any material breach by Executive of this Agreement; or (vii) Executive’s conviction (including any plea of guilty or nolo contendere) of any criminal act involving fraud, dishonesty, misappropriation or moral turpitude, or that materially and permanently impairs the Executive’s ability to perform his duties with a Group Company; provided that in order for the Company’s termination or other claim based upon Cause to be effective hereunder with respect to any failure or violation that the Board reasonably determines to be susceptible of cure, Executive must have failed to cure such failure or violation during a period of thirty (30) days after Executive receives notice from the Company of such failure or violation.

 

“Change in Control” means the occurrence of any of the following events after the Effective Date:

 

(i) The acquisition by one person, or more than one person acting as a group, of ownership of stock of the Company that, together with stock held by such person or group (in each case, directly or through attribution), constitutes more than fifty percent (50%) of the total fair market value or total voting power of the stock of the Company (provided that, if any person or more than one person acting as a group is considered to own more than fifty percent (50%) of the total fair market value or total voting power of the stock of the Company, the acquisition of additional control by the same person or persons will not constitute a Change in Control); or (ii) One person, or more than one person acting as a group, acquires (or has acquired during the twelve (12)-month period ending on the date of the most recent acquisition by such person or group) assets from the Company that have a total gross fair market value (determined without regard to any liabilities associated with such assets) equal to or more than forty (40%) of the total gross fair market value of all of the assets of the Company immediately before such acquisition or acquisitions.

 

 


 

 

Persons will not be considered to be acting as a group solely because they purchase or own stock of the same corporation at the same time, or as a result of the same public offering. However, persons will be considered to be acting as a group if they are owners of a corporation that enters into a merger, consolidation, purchase or acquisition of stock, or similar business transaction with the Company. Notwithstanding the foregoing, solely for purposes of any payment or benefit under this Agreement that constitutes “deferred compensation” for purposes of “Section 409A” (as defined below), a “Change in Control” will not occur unless such Change in Control also constitutes a “change in the ownership of a corporation,” a “change in the effective control of a corporation,” or a “change in the ownership of a substantial portion of the assets of the corporation,” in each case within the meaning of Section 409A.

 

“Code” means the United States Internal Revenue Code of 1986, as amended, and any applicable regulations and administrative guidelines.

 

“Committee” means the compensation committee of the Soluna Board.

 

“Disability” means Executive’s inability to perform the essential duties, responsibilities and functions of Executive’s position with the Company for a continuous period of ninety (90) days as a result of any mental or physical disability or incapacity, with or without reasonable accommodation, all as determined by the Board in its reasonable discretion. Executive shall cooperate in all respects with the Company if a question arises as to whether Executive has become Disabled (including, subject to restrictions under any applicable law, submitting to an examination by a medical doctor or other health care specialists the Company selects and authorizing such medical doctor or such other health care specialist to provide an opinion to the Company as to whether or not Executive’s condition falls within the definition of “Disability”, but without disclosing any details of Executive’s medical or psychological condition). Executive shall have the right to challenge any such opinion with a medical opinion of Executive’s own medical doctor or health care specialist. In the event that the conclusions reached by such medical doctors or healthcare specialists as to the question of whether or not Executive has a Disability differ, then the two medical doctors or health care specialists providing the opinions shall agree on a third medical doctor or health care specialist, who shall examine Executive and whose determination as to whether Executive has become disabled shall be binding on the parties.

 

“Good Reason” means the occurrence of one or more of the following without Executive’s express written consent:

 

(i)            the Company demotes Executive from the position set forth in Section 2(b)(i) or materially reduces Executive’s responsibilities (including reporting responsibilities) in a manner inconsistent with Executive’s position, other than temporarily while Executive is physically or mentally incapacitated to a degree that would constitute a Disability if it continued for the requisite number of days, or as required by applicable law;

 

(ii) the Company materially breaches this Agreement, including, without limitation, by materially reducing Executive’s compensation hereunder, including any material benefits or material reimbursements to be provided to Executive hereunder (in each case, other than in connection with an across the board reduction of such compensation, benefits or reimbursements applicable to senior executives of the Company generally); (iii) the Company causes Executive to report to a Person other than the Board or a committee thereof; or

 

2


 

 

(iv)          the Company changes Executive’s place of work to a location more than thirty (30) miles from the principal location from which he works as of the Effective Date, and such change increases Executive’s one-way commute;

 

provided, in each case, that Executive delivers written notice detailing the specific circumstance alleged to constitute Good Reason to the Company within thirty (30) days after Executive has actual knowledge of the initial existence of such circumstance, the Company fails to remedy such circumstance within thirty (30) days after it receives such notice from Executive, and Executive actually terminates his employment within sixty (60) days following the expiration of the Company’s cure period described above. Otherwise, any claim of such circumstance as “Good Reason” shall be deemed irrevocably waived by Executive.

 

“Group Company” means the Company and each of its parent entities, subsidiary entities, and other affiliates.

 

“Key Performance Objectives” means those Company and/or personal performance objectives proposed by the Soluna CEO, reviewed by the Committee, and approved by the Soluna Board within forty-five (45) days after the beginning of each calendar year during the Employment Period, or, for the calendar year that contains the Effective Date, within forty-five (45) days after the Effective Date.

 

“Person” means an individual, a partnership, a corporation, an association, a limited liability company, a joint stock company, a trust, a joint venture, an unincorporated organization, a governing body of any of the foregoing, or a governmental entity or any department, agency or political subdivision thereof.

 

“Soluna” means Soluna Holdings, Inc.

 

“Soluna CEO” means the individual having the title of Chief Executive Officer of Soluna.

 

2.            Employment.

 

(a)           Employment; Termination. The Company agrees to employ Executive, and Executive hereby accepts employment with the Company, effective as of the Effective Date, upon the terms and conditions set forth in this Agreement. Executive’s employment under this Agreement shall commence on the Effective Date and shall continue for twenty-four (24) calendar months (the “Initial Term”). Effective upon the expiration of the Initial Term and of each “Additional Term” (as defined below), Executive’s employment under this Agreement will be automatically extended, upon the same terms and conditions, for an additional twelve (12)-month period (each, an “Additional Term”), unless, at least ninety (90) calendar days prior to the expiration of the Initial Term or such Additional Term, as applicable, either Executive or the Company notifies the other party hereto in writing that such extension will not take effect. Notwithstanding the foregoing, Executive’s employment under this Agreement, and the Initial Term or any Additional Term, as applicable, shall terminate upon the earlier occurrence of any of the following:

 

(i)            immediately upon Executive’s death;

 

(ii)           immediately upon the determination that Executive is Disabled as set forth above;

 

3


 

(iii)         upon ninety (90) days’ advance written notice from Executive to the Company of Executive’s voluntary resignation of his employment with the Company other than for Good Reason (which the Company may, in its sole discretion, make effective earlier than any notice date);

 

(iv)          immediately upon written notice from Executive to the Company of the Executive's resignation for Good Reason, subject to compliance with the applicable notice and cure requirements in Section 1;

 

(v)           immediately upon written notice from the Company to Executive of the termination of Executive's employment for any reason other than Cause (which, for the avoidance of doubt, will not include any termination described in clauses (i) or (ii) above); and

 

(vi)         immediately upon written notice from the Company to Executive of the termination of Executive's employment for Cause, subject to compliance with the applicable notice and cure requirements in Section 1.

 

As used in this Agreement, the phrase “Employment Period” means Executive’s period of employment from the Effective Date until the date Executive’s employment ends for any reason. The effective date of any termination of the Employment Period, and of Executive’s employment hereunder, is hereinafter referred to as the “Termination Date.” Effective upon any Termination Date, this Agreement shall automatically terminate and shall be of no further force or effect, except as otherwise provided in Section 7(a) hereof, and Executive shall immediately resign, in writing, from all positions then held by Executive with the Company and its affiliates unless otherwise requested by the Company and agreed to by Executive.

 

For the avoidance of doubt, Executive’s employment is at-will and either Executive or the Company may terminate the Employment Period at any time, for any or no reason. The provisions in Section 2(d) shall govern the amount of compensation and benefits, if any, to be provided to Executive upon termination of the Employment Period and of Executive’s employment hereunder, and do not alter the Company’s right to terminate Executive’s employment at any time.

 

(b)          Position and Duties.

 

(i)            Position. Commencing on the Effective Date and continuing during the Employment Period, Executive shall serve as the President and Chief Executive Officer of the Company and shall report directly to the Board or a committee thereof.

 

(ii)           Responsibilities. In Executive’s capacity set forth in Section 2(b)(i), Executive will provide strategic and tactical leadership to the Company, driving financial performance, managing the leadership team, and working with the Board or a committee thereof to create value for constituents and elevate the Company’s reputation with all constituents, including current and prospective partners, and will have such other and further duties and responsibilities as are customarily exercised by an individual serving in Executive’s capacity at an entity of the Company’s size and nature, including but not limited to direct supervision of and reporting from all other Company personnel. Executive shall also perform and have all such other and further duties and responsibilities commensurate with Executive’s position as and to the extent directed or assigned by the Board or a committee thereof, and shall have such power and authority as shall reasonably be required to enable him to perform such duties and responsibilities hereunder. Executive will also have such other duties and responsibilities, consistent with Executive’s position, as are set forth in the Company’s organizational documents from time to time, and Executive will faithfully perform all of Executive’s duties hereunder to the best of Executive’s ability. The Soluna Board or the Committee will provide a performance review to Executive on no less than an annual basis.

 

4


 

(iii)         Time to be Devoted to Employment. Except for vacation in accordance with Company policy, absences due to temporary illness and other absences resulting from a Disability, Executive shall (A) devote substantially all of Executive’s business time, attention, energy and skill to the Company’s business, subject, however, to such reasonable time and effort as the Executive shall be required to devote to those efforts and activities set forth in Exhibit A (the “Outside Responsibilities”); provided that Executive’s Outside Responsibilities shall not, individually or in the aggregate, materially interfere with the Executive’s ability to discharge his duties and responsibilities hereunder; (B) use Executive’s best efforts to promote the success of the Company’s businesses, and (C) cooperate fully with the Board or a committee thereof in advancing the Company’s best interests. During the Employment Period, other than with respect to any of the Outside Responsibilities, Executive shall not engage in any other business activity which, in the Board’s reasonable judgment, would conflict with Executive’s ability to perform his duties hereunder, whether or not such activity is pursued for gain, profit or other pecuniary advantage.

 

(iv)          Work Location. Executive’s principal place of work shall be located in Albany, New York, or such other location as Executive and the Company agree upon from time to time.

 

(v)           Policies. Executive will be subject to, and will comply with, the policies, standards and procedures generally applicable and made available to the Company’s senior management employees from time to time.

 

(c)          Base Salary and Benefits.

 

(i)            Base Salary. During the Employment Period, the Company shall pay to Executive a base salary (the “Base Salary”) at the annual rate of One Hundred Eighty Thousand Three Hundred Fifty Dollars ($180,350). The Company shall pay the Base Salary in regular installments in accordance with the Company’s general payroll practices, subject to customary withholding, payroll and other taxes. The Base Salary will be subject to annual review by the Soluna Board or the Committee during the Employment Period and, at the Soluna Board’s or the Committee’s sole option, may be increased, provided that at a minimum there shall be annual cost of living increases proportionate to annual increases in the consumer price index published by the U.S. Bureau of Labor Statistics, and following any such increase for all purposes hereunder such changed amount shall be Executive’s “Base Salary.”

 

(ii)           Performance Bonus. In addition to the Base Salary, for each calendar year ending during the Employment Period (each, a “Bonus Year”), Executive shall be eligible to receive an annual bonus based on Executive's performance with respect to the Key Performance Objectives in such Bonus Year (the “Performance Bonus”). Following the completion of each Bonus Year, the Soluna Board or the Committee shall determine, in good faith, whether Executive has achieved the Key Performance Objectives for such year. Executive’s target Performance Bonus for each Bonus Year will be a cash bonus equal to no less than sixty percent (60%) of the Executive’s Base Salary as of the beginning of such Bonus Year (or, for the Bonus Year ending December 31, 2021, as of January 1, 2021), unless the Soluna Board or the Committee and Executive agree on a different target amount for such Bonus Year within forty-five (45) days after the start of such Bonus Year. The Performance Bonus shall be prorated on a proportionate basis if Executive achieves at least 75%, but less than 100%, of the applicable Key Performance Objectives (it being understood that no Performance Bonus shall be paid if Executive fails to achieve at least 75% of the applicable Key Performance Objectives). No portion of the Performance Bonus is guaranteed but, if awarded based on achievement of all or a portion of the applicable Key Performance Objectives, shall be earned by and paid to Executive by no later than March 15 of the calendar year next following the Bonus Year to which it relates, contingent on Executive’s continued employment with the Company through the last day of such Bonus Year. The Performance Bonus shall be prorated for any partial Bonus Year (other than for the Bonus Year ending December 31, 2021). The Performance Bonus shall be determined and paid in such a manner as qualifies for the “short-term deferral” exemption from Section 409A.

 

5


 

(iii)         Transaction Bonus. In the event of a Change in Control occurring (x) while Executive is in active employment with the Company or (y) within three (3) months following a termination of Executive’s employment (A) by reason of Executive’s death under Section 2(a)(i), (B) by the Company due to Executive’s Disability under Section 2(a)(ii), (C) by Executive for Good Reason under Section 2(a)(iv), or (D) by the Company other than for Cause under Section 2(a)(v), and provided, in each case, that Executive remains in compliance with this Agreement (including Section 3) at all times, Executive shall earn a cash incentive payment (the “Transaction Bonus”) calculated as the sum of the following amounts:

 

(1)           Five and one third percent (5.33%) of the “Gross Sales Price” (as defined below) exceeding ten million dollars ($10,000,000) but not exceeding twelve million dollars ($12,000,000), but only if the Company achieves its budget targets (as determined by the Board in its sole and absolute discretion), plus

 

(2)           Three and one third percent (3.33%) of the Gross Sales Price exceeding twelve million dollars ($12,000,000) but not exceeding fifteen million dollars ($15,000,000), plus

 

(3)           Two percent (2.0%) of the Gross Sales Price exceeding fifteen million dollars ($15,000,000) but not exceeding twenty million dollars ($20,000,000), plus

 

(4)           Four percent (4.0%) of the Gross Sales Price exceeding twenty million dollars ($20,000,000).

 

For purposes of this Agreement, “Gross Sales Price” means the aggregate dollar amount of any cash consideration, plus the aggregate fair market value of any non-cash consideration, received or to be received by the Company or its equity holders directly as a result of a Change in Control. The Gross Sales Price will be determined by the Soluna Board in its sole and absolute discretion, and such determination will be final and binding on Executive and the Company.

 

The Transaction Bonus, if any, to which Executive becomes entitled hereunder shall be paid to Executive in a single lump sum in cash within sixty (60) calendar days following the consummation of the Change in Control.

 

(iv)          Business Expenses. The Company shall reimburse Executive for all reasonable expenses that he incurs in performing his duties hereunder during the Employment Period, in each case subject to the terms and conditions of the Company’s policies in effect from time to time with respect to travel, entertainment and other business expenses. Executive shall furnish the Company with evidence relating to such expenses as the Company reasonably requires to substantiate such expenses.

 

(v)            Employee Benefits. Executive will be eligible for all customary and usual employee benefits generally available to the Company’s executives subject to the terms and conditions of the Company’s benefit plan documents. The Company reserves the right to change or eliminate its employee benefits arrangements on a prospective basis, at any time and without notice. Executive will be eligible for vacation time during the Employment Period in accordance with the Company’s vacation policy. Following the Termination Date, Executive may have the right to continue coverage under the Company’s health insurance plan for a period of time in accordance with and subject to the Consolidated Omnibus Budget Reconciliation Act of 1985, as amended (“COBRA”).

 

6


 

(d)          Effect of Termination.

 

(i)           If the Employment Period, and Executive’s employment hereunder, is terminated (A) due to non-renewal of the Employment Period by either party under Section 2(a), (B) by the Company for Cause under Section 2(a)(vi) or due to Executive’s Disability under Section 2(a)(ii), (C) by reason of Executive’s death under Section 2(a)(i), or (D) by Executive’s resignation other than for Good Reason under Section 2(a)(iii), Executive or his estate, as the case may be, shall be entitled to the following (collectively, the payments and benefits described in Sections 2(d)(i)(1) through 2(d)(i)(4) hereof shall be hereafter referred to as the “Accrued Benefits”):

 

(1)       all previously earned and accrued but unpaid Base Salary through the Termination Date, paid on the next regularly scheduled date for the Company to make payroll payments following Termination Date or such earlier date as may be required by applicable law;

 

(2)       subject to Section 2(c)(iv), all previously approved but unreimbursed expenses incurred by the Executive through the Termination Date, paid within sixty (60) days following Termination Date or such earlier date as may be required by applicable law or as set forth in the Company’s expense reimbursement policy;

 

(3)       any accrued but unused paid vacation time, paid subject to and in accordance with Company policy; and

 

(4)       all other payments and benefits to which Executive shall be entitled under the terms of any employee benefit plan of the Company, paid or provided subject to and in accordance with the terms of such plan.

 

(ii)          If the Employment Period, and Executive’s employment hereunder, is terminated (A) by the Company other than for Cause under Section 2(a)(v) or (B) by Executive for Good Reason under Section 2(a)(iv), Executive shall be entitled to the Accrued Benefits and, subject to Executive’s compliance with the Release Condition in Section 2(d)(iv), may also receive the following additional payments:

 

(1)       a severance payment in an amount equal to Executive’s Base Salary for twelve (12) months (the “Severance Period”), paid in equal monthly installments on regular Company payroll dates over the Severance Period following the Termination Date (the “Severance Payment”); provided that the first installment of the Severance Payment will be paid on the first regular Company payroll date next following the sixtieth (60th) calendar day following the Termination Date and will include payment of any installment payments that were otherwise due prior thereto;

 

(2)       the Performance Bonus (if any) earned for the most recently-completed Bonus Year preceding the Termination Date in accordance with Section 2(c)(ii) based on actual attainment of the applicable Key Performance Objectives for such year, to the extent unpaid as of the Termination Date, paid in a single lump sum in cash on the first regular Company payroll date next following the sixtieth (60th) calendar day following the Termination Date (the “Prior Year Bonus”); and

 

7


 

(3)       subject to (x) Executive’s eligibility for and timely election of continuation coverage under COBRA, and (y) Executive’s continued copayment of premiums at the same level and cost to Executive as if Executive were an employee of the Company (excluding, for purposes of calculating cost, an employee’s ability to pay premiums with pre-tax dollars), continued copayment by the Company for Executive’s coverage under the Company’s group health plan during the twelve (12)-month period following the Termination Date to the same extent that the Company paid for such coverage immediately prior to the Termination Date, in a manner intended to avoid any excise tax under Section 4980D of the Code, subject to the eligibility requirements and other terms and conditions of such insurance coverage (the “COBRA Subsidy”).

 

(iii)        The treatment of any equity or equity-based awards held by Executive upon any termination of Executive’s employment hereunder shall be subject to the documents and agreements governing such awards.

 

(iv)         Executive shall be eligible to receive the Severance Payment, the Prior Year Bonus, and the COBRA Subsidy only if (A) Executive remains in compliance with Section 3 at all times, and (B) Executive has executed and delivered to the Company a general release of claims in the form then provided by the Company to Executive (the “General Release”), which General Release has become effective and irrevocable according to its terms no later than 60 days following the Termination Date, and only so long as Executive has not revoked or breached any of the provisions of the General Release and does not subsequently breach any such provisions (the “Release Condition”). To the extent that any amount under Section 2(d) constitutes “deferred compensation” for purposes of Section 409A, any payment of such amount scheduled to occur during the first sixty (60) days following the Termination Date shall not be made until the Company’s first regularly scheduled pay period next following the sixtieth (60th) day after the Termination Date and shall include payment of all amounts that were otherwise scheduled to be paid prior thereto.

 

(v)          The payments and benefits described in this Section 2(d) shall be in full and complete satisfaction of Executive’s rights and entitlements under this Agreement and any other claims that Executive may have in respect of Executive’s employment with the Company or any of its affiliates, and Executive acknowledges that such amounts are fair and reasonable, and are Executive’s sole and exclusive remedy, in lieu of all other remedies at law or in equity, with respect to the termination of Executive’s employment hereunder or any breach of this Agreement. As of the date of the final payment described in this Section 2(d), the Company shall not have any further obligation to Executive under this Agreement or otherwise, except as may be required by law.

 

(vi)         The Company’s obligation to make the payments provided for in this Agreement and otherwise to perform its obligations hereunder shall not be affected by any set-off, counterclaim, recoupment, defense or other claim, right or action which the Company may have against Executive or others. In no event shall Executive be obligated to seek other employment or take any other action by way of mitigation of the amounts payable to Executive under any of the provisions of this Agreement and such amounts shall not be reduced whether or not Executive obtains other employment.

 

(e)          Indemnification; D&O Coverage.

 

(i)           The Company will indemnify Executive to the full extent required under the Company’s Certificate of Incorporation and Bylaws, and under applicable law.

 

(ii)          Soluna or the Company will maintain a directors’ and officers’ liability insurance policy (or policies) providing coverage for Executive that is no less favorable to him in any respect (including as to the length of any post-employment tail coverage) than the coverage then being provided to any other officer or director of Soluna.

 

8


 

3.           Proprietary Information, Developments, Noncompetition and Nonsolicitation. For purposes of this Section 3, the term “Company” shall include the Company and each other Group Company, including, without limitation, Soluna.

 

(a)          Proprietary and Confidential Information.

 

(i)            Executive agrees that all information, whether or not in writing, of a private, secret or confidential nature concerning the business, business relationships or financial affairs of the Company (collectively, “Proprietary Information”) is and shall be the exclusive property of the Company. Proprietary Information includes, but is not limited to, discoveries, inventions, products, product improvements, product enhancements, business and technical processes, methods, techniques, machines, formulas, compositions, manufactures, compounds, negotiation strategies and positions, projects, developments, plans (including business, financial and marketing plans and reports), research data, clinical data, financial data (including sales costs, profits, pricing methods, and accounting methods), personnel data, computer programs (including software used pursuant to a license agreement), customer and supplier lists, and contacts at or knowledge of customers or prospective customers of the Company. Executive will not disclose any Proprietary Information to any person or entity other than employees of the Company or use the same for any purposes (other than in the performance of Executive’s duties as an employee of the Company) without written approval by an officer of the Company, either during or after Executive’s employment with the Company, unless and until such Proprietary Information has become public knowledge without fault by Executive.

 

(ii)           Executive agrees that all files, documents, letters, memoranda, reports, records, data, sketches, drawings, models, laboratory notebooks, program listings, computer equipment or devices, computer programs or other written, photographic, or other tangible material containing Proprietary Information, whether created by Executive or others, which shall come into Executive’s custody or possession, shall be and are the exclusive property of the Company to be used by Executive only in the performance of Executive’s duties for the Company and shall not be copied or removed from the Company premises except in the pursuit of the business of the Company. All such materials or copies thereof and all tangible property of the Company in Executive’s custody or possession shall be delivered to the Company, upon the earlier of (A) a request by the Company or (B) termination of the Executive's employment. After such delivery, Executive shall not retain any such materials or copies thereof or any such tangible property of the Company.

 

(iii)          Executive agrees that the obligation not to disclose or to use information and materials of the types set forth in paragraphs (i) and (ii) above, and the obligation to return materials and tangible property set forth in paragraph (ii) above also extends to such types of information, materials and tangible property of the customers of the Company, suppliers to the Company or other third parties who may have disclosed or entrusted the same to the Company or to Executive.

 

(b)          Developments.

 

(i)            Executive will make full and prompt disclosure to the Company of all inventions, creations, improvements, discoveries, trade secrets, secret processes, technology, know-how, methods, developments, software, and works of authorship or other creative works, whether patentable or not (collectively, “Developments"), which are created, made, conceived or reduced to practice by Executive or under Executive’s direction or jointly with others, whether or not during normal working hours or on the premises of the Company. Executive has attached hereto as Exhibit B a list of the developments as of the date of this Agreement which belong to Executive and which Executive shall not assign to the Company (“Prior Developments"), or if no Prior Developments are listed on Exhibit B, Executive represents that there are no such Prior Developments.

 

9


 

(ii)           Executive agrees to assign and does hereby assign to the Company (or any person or entity designated by the Company) rights, title and interest in and to all Developments and all related patents, patent applications, copyrights and copyright applications. However, this Section 3(b)(ii) shall not apply to Prior Developments or to Developments that (A) do not relate to the present or planned business or research and development of the Company and (B) are made and conceived by Executive not during normal working hours, not on the Company's premises and not using the Company's tools, devices, equipment or Proprietary Information. Executive understands that, to the extent this Agreement shall be construed in accordance with the laws of any state that precludes a requirement in an employee agreement to assign certain classes of inventions made by an employee, this Section 3(b)(ii) shall be interpreted not to apply to any invention that a court rules and/or the Company agrees falls within such classes. Executive also hereby waives all claims to moral rights in any Developments.

 

(iii)          Executive agrees to cooperate fully with the Company and to take such further actions as may be necessary or desirable, both during and after Executive’s employment with the Company, with respect to the procurement, maintenance and enforcement of copyrights, patents and other intellectual property rights (both in the United States and foreign countries) relating to Developments. Executive shall sign all papers, including, without limitation, copyright applications, patent applications, declarations, oaths, formal assignments, assignments of priority rights, and powers of attorney, which the Company may deem necessary or desirable in order to protect its rights and interests in any Developments. Executive further agrees that if the Company is unable, after reasonable effort, to secure the Executive’s signature on any such papers, any executive officer of the Company shall be entitled to execute any such papers as the agent and the attorney-in-fact of Executive, and Executive hereby irrevocably designates and appoints each executive officer of the Company as Executive’s agent and attorney-in-fact to execute any such papers on Executive’s behalf, and to take any and all actions as the Company may deem necessary or desirable in order to protect its rights and interests in any Developments, under the conditions described in this sentence.

 

(c)          Other Agreements. Executive hereby represents that, except as Executive has disclosed in writing to the Company, Executive is not bound by the terms of any agreement with any previous employer or other party to refrain from using or disclosing any trade secret or confidential or proprietary information in the course of Executive’s employment with the Company, to refrain from competing, directly or indirectly, with the business of such previous employer or any other party, or to refrain from soliciting employees, customers or suppliers of such previous employer or other party. Executive further represents that Executive’s performance of all the terms of this Agreement and the performance of Executive’s duties as an employee of the Company do not and will not breach any agreement with any prior employer or other party to which Executive is a party (including without limitation any non-disclosure or non-competition agreement), and that Executive will not disclose to the Company or induce the Company to use any confidential or proprietary information or material belonging to any previous employer or others.

 

(d)          United States Government Obligations. Executive acknowledges that the Company from time to time may have agreements with other persons or with the government of the United States of America, or agencies thereof, which impose obligations or restrictions on the Company regarding inventions made during the course of work under such agreements or regarding the confidential nature of such work. Executive agrees to be bound by all such obligations and restrictions that are made known to Executive and to take all action necessary to discharge the obligations of the Company under such agreements.

 

10


 

(e)          Noncompetition. During the Executive’s employment and for a period of one (1) year after the termination or cessation of Executive's employment for any reason, Executive will not directly or indirectly engage in any Competitive Business whether as owner, partner, officer, director, employee, consultant, investor, lender or otherwise, except as the holder of not more than 1% of the outstanding stock of a publicly-held company. For these purposes, “Competitive Business” means any business or enterprise regardless of its location that designs, develops, manufactures, researches, markets, sells or services non-contact measurement systems, including without limitation, electronic computerized general gauging instruments for position, displacement and vibration applications, semiconductor products for wafer characterization of semi-insulating and semiconducting wafers and portable balancing systems for aircraft engineers.

 

(f)           Nonsolicitation. During Executive’s employment and for a period of one (1) year after termination or cessation of Executive’s employment for any reason, Executive will not directly or indirectly:

 

(i)            Either alone or in association with others (A) solicit, recruit, induce, or attempt to solicit, recruit or induce, or permit any organization directly or indirectly controlled by Executive to solicit, recruit, induce, or attempt to solicit, recruit or induce any employee of the Company to leave the employ of the Company, or (B) solicit, recruit, induce, or attempt to solicit, recruit or induce for employment or hire or engage as an independent contractor, or permit any organization directly or indirectly controlled by Executive to solicit, recruit, induce, or attempt to solicit, recruit or induce for employment or hire or engage as an independent contractor, any person who was employed or engaged by the Company at any time during the term of Executive's employment with the Company; provided, however, that this clause (B) shall not apply to any individual's employment with the Company which has been terminated for a period of six months or longer; or

 

(ii)           Either alone or in association with others, solicit, divert or take away, or attempt to solicit, divert or take away, or permit any organization directly or indirectly controlled by Executive to solicit, divert or take away, or attempt to solicit, divert or take away, the business or patronage of any of the clients, customers or accounts, or prospective clients, customers or accounts, of the Company, which were contacted, solicited or served by the Company at any time during the term of Executive's employment with the Company.

 

(g)          Interpretation. If Executive violates the provisions of Sections 3(e) or 3(f) of this Agreement, Executive shall continue to be bound by the restrictions set forth in Sections 3(e) and 3(f) until a period of one (1) year has expired without any violation of such provisions. If any restriction set forth in Sections 3(e) or 3(f) is found by any court of competent jurisdiction to be unenforceable because it extends for too long a period of time or over too great a range of activities or in too broad a geographic area, it shall be interpreted to extend only over the maximum period of time, range of activities or geographic area as to which it may be enforceable.

 

(h)          Employee Acknowledgement and Equitable Remedies. Executive acknowledges that the restrictions contained in this Section 3 are necessary for the protection of the business and goodwill of the Company and considers the restrictions to be reasonable for such purpose. Executive agrees that any breach of the provisions contained in this Section 3 is likely to cause the Company substantial and irrevocable damage and that therefore, in the event of any breach of this Section 3, Executive agrees that the Company, in addition to such other remedies that may be available, shall be entitled to specific performance and other injunctive relief without posting a bond.

 

11


 

4.            Notices. All notices, demands or other communications to be given or delivered under or by reason of the provisions of this Agreement will be in writing and will be deemed to have been given when delivered personally, the third Business Day after having been mailed by certified or registered mail, return receipt requested and postage prepaid, or the first Business Day after the date sent via a nationally recognized overnight courier. “Business Day” is any day other than a Saturday, Sunday or a day on which banks in New York are required or authorized to be closed. Such notices, demands and other communications will be sent to the address indicated below:

 

To the Company:

 

MTI Instruments, Inc.

Attention: Board of Directors

325 Washington Ave. Extension

Albany NY 12205

 

With a copy (which shall not constitute notice) to:

 

Jackson Lewis P.C. 

Attention: Kenneth C. Weafer, Attorney at Law

677 Broadway, 9th Floor

Albany, NY 12207

 

To Executive:

 

To Executive at Executive’s most recent address in the Company’s records

 

or such other address or to the attention of such other person as the recipient party shall have specified by prior written notice to the sending party.

 

5.           Dispute Resolution.

 

(a)           Agreement to Arbitrate. Except as otherwise expressly provided in Section 3(h) hereof, any dispute, claim, or controversy between the parties arising out of or in connection with this Agreement, or the employment relationship, shall be settled by binding arbitration under the Employment Arbitration Rules of the American Arbitration Association then in effect, provided, however, either party may request provisional, injunctive or extraordinary relief from a court of competent jurisdiction, under applicable law of the State of New York, if necessary to preserve the status quo pending arbitration. The arbitrator shall have the exclusive authority to resolve any dispute relating to the arbitrability of any individual claim or the enforceability or formation of this Agreement. The arbitration proceeding shall be conducted in English, before a single arbitrator, and any hearing shall be held in Albany, New York. The cost of such arbitration shall be borne by the Company; however, each party shall be responsible for its own attorney fees. This arbitration clause shall survive the termination of this Agreement. This Agreement to arbitrate disputes is governed by the Federal Arbitration Act (9 U.S.C. Sections 1, et seq.). The arbitrator shall apply the substantive law relating to all claims and defenses to be arbitrated the same as if the matter had been heard in court, including with respect to the award of any remedy or relief on an individual basis and any award of costs and attorneys’ fees to the prevailing party. The decision of the arbitrator shall be binding, and judgment thereon may be entered by any court of competent jurisdiction. Any type of class, collective claims or multi-party claims are expressly prohibited, and the arbitrator will have no authority to alter the parties’ agreement in this regard. In the event of any legal proceeding between the Company and Executive relating to this Agreement, neither party may claim the right to a trial by jury, and both parties waive any right they may have under applicable law or otherwise to a trial by jury. To the extent permitted by applicable law, the arbitration shall be kept confidential and the existence of the arbitration proceeding and any element of it (including but not limited to any pleadings, briefs or other documents submitted and exchanged and testimony or other oral submissions and any awards made) shall not be disclosed beyond the arbitrator, the parties hereto, their counsel and any person to whom disclosure is necessary to the conduct of the proceeding. Nothing in this Agreement prevents Executive from reporting good faith allegations of unlawful employment practices to appropriate federal, state or local agencies; reporting any good faith allegation of criminal conduct to any appropriate federal, state, or local official; participating in a proceeding with any appropriate federal, state, or local government agency enforcing discrimination laws; making any truthful statements or disclosures required by law, regulation, or legal process; or requesting or receiving confidential legal advice.

 

12


 

(b)           Consideration. The mutual promise by the Company and Executive to arbitrate all disputes between them, rather than to litigate them before the courts or other bodies, provides the consideration for this agreement to arbitrate. The Company’s offer of employment to Executive and the Company’s agreement to pay all fees and costs unique to arbitration serve as additional consideration.

 

6.            Clawback. All amounts paid or provided to Executive hereunder shall be subject to any clawback or recoupment policy that may be maintained by the Company from time to time, and the requirements of any law or regulation applicable to the Company and governing the clawback or recoupment of executive compensation, or as set forth in any final non-appealable order by any court of competent jurisdiction or arbitrator.

 

7.           Miscellaneous.

 

(a)           Survival. Sections 2(d), and 3 through 7 shall survive and shall continue in full force and effect in accordance with their respective terms notwithstanding any expiration or termination of the Employment Period and/or this Agreement.

 

(b)           Severability. Whenever possible, each provision of this Agreement will be interpreted in such manner as to be effective and valid under applicable law, but if any provision of this Agreement is held to be invalid, illegal or unenforceable in any respect under any applicable law or rule in any jurisdiction, such invalidity, illegality or unenforceability will not affect any other provision or any other jurisdiction, but this Agreement will be reformed, construed and enforced in such jurisdiction as if such invalid, illegal or unenforceable provision had never been contained herein.

 

(c)           Complete Agreement. This Agreement, together with its exhibits and attachments, embodies the parties’ complete agreement and understanding regarding the subject matter hereof and supersedes and preempts any prior understandings, agreements or representations by the parties, written or oral, which may have related to the subject matter hereof in any way. For the avoidance of doubt, agreements superseded and preempted hereby shall include, without limitation, the Proprietary Information, Developments, Non-Competition and Non-Solicitation Agreement between Executive and the Company, dated August 28, 2019, but shall not include the Confidentiality Agreement or the Entrance Interview Acknowledgement between the Executive and the Company, each dated August 28, 2019.

 

(d)           Successors and Assigns. Except as otherwise provided herein, this Agreement shall bind and inure to the benefit of and be enforceable by Executive and the Company, and their respective heirs, executors, successors, assigns and legal representatives; provided, that the services provided by Executive hereunder are of a personal nature and the rights and obligations of Executive hereunder shall not be assignable. Notwithstanding the foregoing, the Company may assign this Agreement, and its rights and obligations hereunder, to any successor to all or substantially all of the business and/or assets of the Company, provided that the Company shall require such successor to expressly assume and agree to perform this Agreement in the same manner and to the same extent that the Company would be required to perform it if no such succession had taken place (and any such successor shall thereafter become the “Company” for purposes of this Agreement), and provided further that nothing herein shall modify any rights Executive has pursuant to this Agreement that are triggered by a “Change in Control” (or similar term).

 

13


 

(e)          Governing Law and Forum Selection Clause. Except as provided in Section 5, the law of the State of New York shall govern all questions concerning the construction, validity, interpretation and enforceability of this Agreement, and the performance of the obligations imposed by this Agreement, without giving effect to any choice of law or conflict of law rules or provisions. Each party submits to the jurisdiction of the state and federal courts located in Albany, New York in any action or proceeding arising out of or relating to this Agreement and agrees that all claims in respect of the action or proceeding may be heard and determined in any such court. Each party also agrees not to bring any action or proceeding arising out of or relating to this Agreement in any other court. Each party waives any defense of inconvenient forum to the maintenance of any action or proceeding so brought and waives any bond, surety or other security that might be required of the other party with respect thereto. A party may make service on the other party by sending or delivering a copy of the process to the party to be served at the address and in the manner provided for the giving of notices in Section 4. Nothing in this Section 7(e), however, shall affect a party’s right to serve legal process in any other manner permitted by law or at equity. Each party agrees that a final judgment in any action or proceeding so brought shall be conclusive and may be enforced by suit on the judgment or in any other manner provided by law or at equity.

 

(f)           Executive’s Cooperation. During the Employment Period and thereafter Executive shall cooperate with the Company and its affiliates in any internal investigation or administrative, regulatory or judicial proceeding as reasonably requested by the Company (including Executive being available to the Company upon reasonable notice for interviews and factual investigations, appearing at the Company's request to give testimony without requiring service of a subpoena or other legal process, volunteering to the Company all pertinent information and turning over to the Company all relevant documents which are or may come into Executive's possession, all at times and on schedules that are reasonably consistent with Executive's other permitted activities and commitments). Such services will be without additional compensation if Executive is then employed by the Company and for reasonable compensation if Executive is not then employed by the Company. The provisions of this Section 7(f) shall not apply to legal actions between Executive and the Company.

 

(g)          Amendment and Waiver. The provisions of this Agreement may be amended and waived only with the prior written consent of the Company and Executive. No waiver shall be effective unless in a writing signed by the person against whom such waiver is sought to be enforced. The failure of a party to insist upon strict adherence to any term of this Agreement on any occasion shall not be considered a waiver thereof or deprive that party of the right thereafter to insist upon strict adherence to that term or any other term of this Agreement.

 

(h)          No Strict Construction. The language used in this Agreement shall be deemed to be the language chosen by the parties to express their mutual intent, and no rule of strict construction shall be applied against either party.

 

(i)           Tax Matters.

 

(1)           Tax Withholding. The Company shall withhold from any compensation and benefits payable under this Agreement all applicable federal, state, local, or other taxes, and any other applicable withholdings.

 

14


 

(2)          Section 409A.

 

(i)        The parties intend for payments and benefits hereunder to either comply with, or be exempt from, Section 409A of the Code and the regulations promulgated thereunder (collectively “Section 409A”) and, accordingly, to the maximum extent permitted, this Agreement shall be interpreted and construed consistent with such intent. To the extent that any provision hereof is modified in order to comply with Section 409A, such modification shall be made in good faith and shall, to the maximum extent reasonably possible, maintain the original intent and economic benefit to Executive and the Company of the applicable provision without violating the provisions of Section 409A. Notwithstanding the foregoing, the Company does not guarantee any particular tax result, and in no event whatsoever shall the Company, its affiliates, or their respective officers, directors, employees, counsel or other service providers be liable for any tax, interest or penalty that may be imposed on Executive by Section 409A or damages for failing to comply with Section 409A.

 

(ii)       To the extent that reimbursements or other in-kind benefits hereunder constitute “deferred compensation” for purposes of Section 409A, (x) all expenses or other reimbursements hereunder shall be made on or prior to the last day of the taxable year following the taxable year in which such expenses were incurred by Executive, (y) any right to reimbursement or in-kind benefits shall not be subject to liquidation or exchange for another benefit, and (z) no such reimbursement, expenses eligible for reimbursement, or in-kind benefits provided in any taxable year shall in any way affect the expenses eligible for reimbursement, or in-kind benefits to be provided, in any other taxable year.

 

(iii)       For purposes of Section 409A, Executive’s right to receive installment payments pursuant to this Agreement shall be treated as a right to receive a series of separate and distinct payments. Whenever a payment hereunder specifies a payment period with reference to a number of days, the actual date of payment within the specified period shall be within the sole discretion of the Company.

 

(iv)      Any other provision of this Agreement to the contrary notwithstanding, in no event shall any payment or benefit hereunder that constitutes “deferred compensation” for purposes of Section 409A be subject to offset by any other amount unless otherwise permitted by Section 409A.

 

(v)       A termination of employment shall not be deemed to have occurred for purposes of any provision of this Agreement providing for the payment of any amounts or benefits upon or following a termination of employment unless such termination is also a “separation from service” within the meaning of Section 409A, and, for purposes of any such provision, all references in this Agreement to Executive’s “termination”, “termination of employment” and like terms shall mean Executive’s “separation from service” with the Company.

 

(vi)       Notwithstanding any other provision of this Agreement to the contrary, if, at the time of Executive’s separation from service, Executive is a “Specified Employee”, then the Company will defer the payment or commencement of any nonqualified deferred compensation subject to Section 409A payable upon separation from service (without any reduction in such payments or benefits ultimately paid or provided to Executive) until the date that is six (6) months following separation from service or, if earlier, the earliest other date as is permitted under Section 409A (and any amounts that otherwise would have been paid during this deferral period will be paid in a lump sum on the day after the expiration of the six (6) month period or such shorter period, if applicable). Executive will be a “Specified Employee” for purposes of this Agreement if, on the date of Executive’s separation from service, Executive is an individual who is, under the method of determination adopted by the Company, designated as, or within the category of employees deemed to be, a “Specified Employee” within the meaning and in accordance with Treasury Regulation Section 1.409A-1(i). The Company shall determine in its sole discretion all matters relating to who is a “Specified Employee” and the application of and effects of the change in such determination.

 

15


 

(j)            Parachute Payments. In the event that any payments and other benefits provided for in this Agreement or otherwise payable to Executive constitute “parachute payments” within the meaning of Section 280G of the Code, and, but for this paragraph, would be subject to the excise tax imposed by Section 4999 of the Code, then any post-termination severance payments and benefits payable under this Agreement or otherwise will be either (1) delivered in full or (2) delivered as to such lesser extent which would result in no portion of such payments and benefits being subject to excise tax under Section 4999 of the Code, whichever of the foregoing amounts, taking into account the applicable federal, state and local income taxes and the excise tax imposed by Section 4999 of the Code, results in the receipt by Executive, on an after-tax basis, of the greatest amount of payments and benefits, notwithstanding that all or some portion of such benefits may be taxable under Section 4999 of the Code. If a reduction in Executive’s payments and benefits is necessitated by the preceding sentence, such reduction will occur in the following order: (i) any cash severance based on a multiple of base salary or annual bonus, (ii) any other cash amounts payable to Executive, (iii) benefits valued as parachute payments, and (iv) acceleration of vesting of any equity awards. Unless the Company and Executive otherwise agree in writing, any determination required under this paragraph will be made in writing by the Company’s or its affiliates’ independent public accountants (the “Firm”), whose determination will be conclusive and binding upon Executive and the Company. For purposes of making the calculations required by this paragraph, the Firm may make reasonable assumptions and approximations concerning applicable taxes and may rely on reasonable, good faith interpretations concerning the application of Sections 280G and 4999 of the Code. The Company and Executive will furnish to the Firm such information and documents as the Firm may reasonably request in order to make a determination under this paragraph. The Company will bear all costs the Firm may incur in connection with any calculations contemplated by this paragraph.

 

(k)           Headings. Section headings are used herein for convenience of reference only and shall not affect the meaning of any provision of this Agreement.

 

(l)            Counterparts; Facsimile Signatures. This Agreement may be executed in separate counterparts, each of which is deemed to be an original and all of which taken together constitute one and the same agreement. Facsimile, PDF, and electronic counterpart signatures to and versions of this Agreement shall be acceptable and binding on the parties.

 

[Signature Page Follows]

 

16


 

IN WITNESS WHEREOF, the parties have executed this Agreement on or as of the 20 day of January, 2022.

       
  MTI INSTRUMENTS, INC.
       
  By: /s/ Thomas Marusak
       
  Name: Thomas Marusak
       
  Its: Chairman Compensation Committee
       
  EXECUTIVE
       
  /s/ Moshe Binyamin
  Moshe Binyamin, CEO, President MTI Instruments Inc.

 

17


 

EXHIBIT A

 

OUTSIDE RESPONSIBILITIES

 

[Executive to provide proposed list, if any.]

 

 


 

EXHIBIT B

 

PRIOR DEVELOPMENTS

 

None